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 Context: Evidence-based practice (EBP) has become a point of emphasis in 
athletic training education and clinical practice.  One approach to EBP is utilizing clinical 
prediction models (CPM) to assist clinicians in the screening, diagnosis, prognosis, and 
treatment of injury.  A number of isolated risk factors, which can be categorized as: (a) 
self-report outcome scores, (b) sport performance factors, or (c) functional performance 
measures (FPMs), have been identified and suggested to be causal with regard to upper-
extremity (UE) sports related injury (SRI) in baseball athletes.  Objective: to develop a 
preliminary CPM for UE SRI derived from multiple factors specific to self-reported 
outcome measures, sport performance risk factors, and FPMs.  Design:  Retrospective 
cohort study.  Setting: National Collegiate Athletic Association Division I baseball 
program.  Subjects: Thirty-six athletes who completed the preseason pre-participation 
examination, the Kerlan-Jobe Orthopaedic Clinic overhead athlete shoulder and elbow 
score (KJOC-SES,) and the Targeted Enhanced Athletic Movement Screen (TEAM-S).  
Main Outcome Measures: Independent variables for this study included the self-reported 
outcome measures (KJOC-SES), sport performance risk factors, and FPMs (TEAM-S).  
The dependent variable for this study was self-reported history of UE SRI.  Results:  
Univariate analyses identified nine predictor variables that differed between injured and 
non-injured athletes (p ≤ 0.10): KJOC-SES, playing position (pitcher), single leg squat 
stride foot, single leg squat balance foot, shoulder mobility test throwing arm, shoulder 
 
mobility test non-throwing arm, CKCUEST  (TEAM-S score), and CKCUEST (absolute 
score). Forward step-wise logistic regression yielded a resultant two-factor clinical 
prediction model consisting of playing position and KJOC-SES. The two-factor CPM 
based on KJOC-SES scores ≤ 86 and playing position (pitcher) yielded diagnostic utility 
measures as follows:  Sensitivity of 83% (95% CI: 0.55 to 95); Specificity of 95% (95% 
CI: 79 to 99); Positive likelihood ratio of 22.0 (95% CI: 2.88 to 138.5); and negative 
likelihood ratio of 0.17 (95% CI: 0.04 to 0.61).  Conclusion: A preliminary two-factor 
CPM comprised of KJOC-SES (≤ 86) and playing position (pitcher) retrospectively 
predicted UE SRI in a cohort of baseball players with strong diagnostic utility.  
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CHAPTER I 
 
INTRODUCTION 
 
 
The concepts of evidence-based practice (EBP) have recently become a point of 
emphasis in athletic training clinical practice (BOC, 2010; NATA, 2010).  Coinciding 
with this, educational reform in entry-level athletic training education has established 
competencies related to the development of EBP knowledge and skills (NATA, 2011).  
Although EBP may seem new within athletic training professional practice and 
education, the concepts have been well established in other healthcare professions for 
over 25 years (AMA, 2002; Guyatt, Rennie, Meade, & Cook, 2008; Sackett, Straus, 
Richardson, Rosenberg, & Haynes, 1997).  The lag in athletic training’s alignment with 
EBP was formally recognized in 2004 (Hootman, 2004).  Initiatives by the National 
Athletic Trainers’ Association (NATA) and Board of Certification (BOC) have raised 
awareness of the importance of EBP; however, advances in evidence–based (EB) clinical 
research are still lacking in the field. 
One approach to EB clinical research relates to the development of clinical 
prediction models (CPMs).  CPMs are statistical models used to estimate probability 
related to screening, diagnosis, prognosis, or treatment interventions (Aronoff et al., 
2010; Banks, Gilmartin, & Fink, 2010; Hicks, Fritz, Delitto, & McGill, 2005; Jewell, 
2011; Steyerberg, 2010).  A combination of factors relating to patient history, 
pathophysiology, symptomology, risk factors, test results, functional performance
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measures (FPMs), and subjective outcome measures can be clustered to aid in clinical 
decision-making (Bainbridge, Nasmith, Orchard, & Wood, 2010; Banks et al., 2010).  
This approach is a departure from an overreliance on single factors or heuristics for 
clinical decision making (Bainbridge et al., 2010).  CPMs can subsequently be an 
important tool for enhancing clinical practice (Atiya, 2002) and provide clinicians with 
the ability to gain clarity when confronted with uncertain or complex patient cases 
(Bainbridge et al., 2010).  The utilization of CPMs is predicated on combining existing 
evidence, patient preference, and clinical expertise to reach an informed clinical decision 
(Glynn & Weisbach, 2011), which in turn are the foundational components of EBP 
(Guyatt et al., 2008; Jewell, 2011; Sackett et al., 1997). 
CPMs should be considered an effective method of improving patient-oriented 
health care (Haworth, Hopkins, Ells, Ackroyd, & Mowat, 1981). This approach is in 
contrast to traditional biomedical research models (Portney & Watkins, 2009), which 
emphasize a causal or linear relationship between pathology and subsequent impairments 
(Portney & Watkins, 2009).  Although the two strategies may seem parallel, the 
biomedical research strategy does not commonly account for the psychosocial 
dimensions of how a patient is affected by injury or illness.  This is most evident in 
biomedical injury prevention paradigms which center largely on etiology, internal and 
external risk factors, incident rates, and categorization of mechanisms (Bahr & 
Krosshaug, 2005; Chalmers, 2002; Van Tiggelen, Wickes, Stevens, Roosen, & 
Witvrouw, 2008).   Although there is a strong relationship between the biomedical model 
and sports related injury (SRI) epidemiology, the model often fails to include the self-
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reported outcome measures in approaching diagnostic, prognostic, and treatment 
strategies (Finch, Gabbe, et al., 2011; Finch, Ullah, & McIntosh, 2011).  This indicates a 
need for patient-centered research models (Hawk, Long, & Boulanger, 1998; Sauers & 
Snyder, 2011) that advance clinical practice (Snyder et al., 2008; Valovich McLeod et al., 
2008). 
Self-reported measures for determining functional disability in clinical research 
have received recent consideration (Cosby & Hertel, 2011; Evans & Lam, 2011; 
Mattacola, 2011; Michener, 2011; Parsons & Snyder, 2011).  Specific to the current 
investigation, self-reported outcome measures have served as a tool for quantifying 
functional disability in upper-extremity (UE) athletes (Alberta et al., 2010; Domb et al., 
2010; Neuman et al., 2011; Sauers, Dykstra, Bay, Bliven, & Snyder, 2011; Thigpen & 
Shanley, 2011).  Development and validation of these self-reported outcome measures 
have been important initial steps in quantifying injury risk stratification and treatment 
outcomes (Alberta et al., 2010; Thigpen & Shanley, 2011).  Qualifying functional status 
through outcome measurement scales represents a departure from relying on return-to-
play (RTP) as a benchmark for successful treatment outcomes in high functioning athletic 
populations (Conway, Jobe, Glousman, & Pink, 1992).  Although RTP is a common 
term, a standardized definition has not emerged in literature.  This can contribute to 
confusion and disagreement between clinicians as to what criteria best define a successful 
treatment outcome (Creighton, Shrier, Shultz, Meeuwisse, & Matheson, 2010).  Specific 
to overhand-throwing athletes, qualifying successful treatment outcomes have been 
problematic because RTP is not sensitive in determining functional status (Alberta et al., 
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2010).  Such problems are highlighted by reports of professional baseball players who 
RTP but still present with functional limitations: e.g., pain, weakness, instability, loss of 
power, altered mechanics, and loss of pitch control (Domb et al., 2010; Neuman et al., 
2011).  Subsequently, the inclusion of self-reported outcome measures should be an 
important component of developing a CPM. 
Baseball is a popular international sport and is played on youth, high school, 
college, and professional levels.  The epidemiology of SRI in baseball has been widely 
reported (Dick et al., 2007; Hootman, Dick, & Agel, 2007; Janda, 2003; Kerut, Kerut, 
Fleisig, & Andrews, 2008; Lyman & Fleisig, 2005; Magra, Caine, & Maffulli, 2007; 
McFarland & Wasik, 1998; Posner, Cameron, Wolf, Belmont, & Owens, 2011).  
Baseball, in comparison to other sports, has a relatively low overall injury rate of 0.23 per 
1,000 athlete exposures (Hootman et al., 2007).  However, the rate of UE SRI for 
baseball players increases in relationship to competitive level with a reported 5% in little 
league and high school (Fleisig et al., 2010), 25% in collegiate (Dick et al., 2007), and 
50% in professional (Anz et al., 2010).  Over the past decade there has been a 
disproportionate rise in UE SRI necessitating surgery (Petty, Andrews, Fleisig, & Cain, 
2004).  This trend had been described as an injury epidemic (Fleisig, 2012) and has led to 
a call for further clarification in understanding the relationship between risk factors and 
injury (McHugh et al., 2012).  Within this population, clarifying the relationship between 
risk factors and UE SRI is complex because most athletes who sustain injury present with 
multiple risk factors (Petty et al., 2004).  In this respect a CPM specific to UE SRI in 
baseball would be beneficial in advancing the body of knowledge in this area. 
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A number of intrinsic risk factors have been identified and suggested to be causal 
to UE SRI in baseball athletes.  These risk factors include: muscle strength deficits 
(Brown, Niehues, Harrah, Yavorsky, & Hirshman, 1988; Yildiz et al., 2006), muscle 
fatigue (Mullaney, McHugh, Donofrio, & Nicholas, 2005); internal and external strength 
imbalance (Lewis & Valentine, 2007); glenohumeral internal rotation deficient (GIRD) 
(Borsa, Dover, Wilk, & Reinold, 2006; Dines, Frank, Akerman, & Yocum, 2009; Wilk et 
al., 2010); scapula dyskinesis (Cooper, Donley, Verna, & Morgan, 2002; Kibler & 
McMullen, 2003); maximum pitch velocity (Bushnell, Anz, Noonan, Torry, & Hawkins, 
2010); pitching volume (Fleisig et al., 2010; Olsen, Fleisig, Dun, Loftice, & Andrews, 
2006); pitch type (e.g., slider , curveball) (Escamilla, Fleisig, Barrentine, Zheng, & 
Andrews, 1998; Fleisig et al., 2010; Fleisig et al., 2006); playing position (Fleisig et al., 
2010; Olsen et al., 2006); throwing biomechanics (Fleisig, Andrews, Dillman, & 
Escamilla, 1995; Fleisig, Barrentine, Escamilla, & Andrews, 1996); and low self-reported 
functional assessment measures (Alberta et al., 2010; Domb et al., 2010; Neuman et al., 
2011).  These risk factors can be categorized into three areas: (a) self-report outcome 
measures, (b) sport performance risk factors, and (c) FPMs.  Despite making progress in 
identifying individual injury risk factors, a single multifactorial injury prediction model 
that accounts for these three risk factor categories has not been presented in literature. 
The studies that have identified a broad range of injury risk factors relating to UE 
SRI in baseball have been largely descriptive (Fleisig et al., 2010; Mueller, Marshall, & 
Kirby, 2001; Olsen et al., 2006).  Corresponding analyses have been dominated by 
traditional statistics (e.g. correlations, descriptive distributions) verses Bayesian inference 
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(e.g. sensitivity, specificity, likelihood ratios).  A Bayesian approach provides an 
advantage in establishing inference based on observed data (Wagenmakers, Lee, 
Lodewyckx, & Iverson, 2008) and can be applied clinically to improve diagnostic and 
prognostic decision-making (Guyatt et al., 2008).  The utilization of Bayesian statistics in 
establishing a CPM may be an important step in identifying a set of factors specific to UE 
SRI in college baseball players to assist in diagnostic and prognostic decision-making.  
Additionally, such a CPM may be clinically beneficial in identifying low- or high-risk 
athletes for injury prevention programs based on evidence.  To date, we have been unable 
to locate any CPMs specific to UE SRI in colligate baseball athletes. 
Although a number of baseball-specific risk factors have been independently 
described (Fleisig et al., 2010; Hootman et al., 2007; Olsen et al., 2006; Wilk et al., 
2010), a multifactorial model has not been developed to aid in the clinical diagnosis of 
UE SRI.  The collective inclusion of self-reported outcome measures (Domb et al., 2010; 
Neuman et al., 2011; Thigpen & Shanley, 2011), sport performance risk factors (Fleisig 
et al., 2010; Olsen et al., 2006), and FPMs (G. Cook, Burton, & Hoogenboom, 2006a, 
2006b; G. Cook, Burton, Kiesel, Rose, & Bryant, 2010; Kiesel, Plisky, & Voight, 2007) 
may be important in establishing a CPM specific to the baseball population. 
As a decision-making tool, CPMs have potential to assist in diagnosis, prognosis, 
and treatment strategies.  This is particularly relevant in the context of complex patient 
groups or injury patterns encountered in clinical practice.  Collegiate baseball players are 
one such specialized patient group and often present with complex UE injury patterns.  
The diagnosis, prognosis, and treatment of UE SRI in collegiate baseball players are 
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complex.  Consequently, there is a need to improve the decision-making process to assist 
clinicians in improving patient outcomes.  A CPM of UE SRI would be an important 
advancement in assisting clinicians in navigating the complexities of this patient 
population.  Therefore, the purpose of this study was to develop a preliminary clinical 
prediction model for UE SRI derived from multiple factors specific to self-reported 
outcome measures, sport performance risk factors, and FPMs in a retrospective cohort of 
collegiate baseball players, and to determine if the model is retrospectively predictive of 
UE SRI. 
Objectives and Hypotheses 
Objective 
To develop and assess a preliminary CPM for UE SRI in a retrospective cohort of 
collegiate baseball players. 
Specific Aim One 
Identify individual factors specific to self-reported outcome measures, sport 
performance risk factors, and FPMs that differ between previously injured and uninjured 
cohorts.  Secondarily to this, through the construction of 2x2 contingency tables we will 
determine the diagnostic utility (as measured by sensitivity, specificity, positive 
likelihood ratio, and negative likelihood ratio) of individual factors that significantly 
differ between injured and uninjured cohorts.  We hypothesized that multiple individual 
factors will be statistically significant in retrospectively predicting UE SRI in a cohort of 
college baseball players. 
  
 
8 
Specific Aim Two 
 Determine whether the individual factors identified in Specific Aim One 
collectively can retrospectively predict injury status.  We hypothesized that a multivariate 
CPM will retrospectively predict UE SRI in a cohort of college baseball players with a 
greater degree of diagnostic utility than individual factor diagnostic utility measures. 
Operational Definitions 
 
1.  The two-by-two (2x2) contingency table used for calculating diagnostic utility values 
is listed in Table 1. 
 
Table 1. 2x2 Contingency Table for Diagnostic Test Results 
  Reference Standard / 
Target Condition 
 
  Positive Negative Total 
Diagnostic Test / 
Clinical Measure / 
Risk Factor 
Positive a 
(True positive) 
b 
(False positive) 
a + b 
Negative c 
(False negative) 
d 
(True negative) 
c + d 
 Total a + c b + d N 
Note. Adapted from Portney & Watkins (2009), and Sackett et al. (1997) 
 
 
2.  Sensitivity: The proportion of subjects with the target condition who will have a 
positive test result (Guyatt et al., 2008; Sackett et al., 1997; Wagenmakers et al., 2008).  
Sensitivity = (a/(a + c) (Portney & Watkins, 2009). 
3.  Specificity: The proportion of subjects without the target condition who will have a 
negative test result (Guyatt et al., 2008; Sackett et al., 1997; Wagenmakers et al., 2008).  
Specificity = (d/(b + d) (Portney & Watkins, 2009). 
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4.  Positive Likelihood Ratio (LR+): The probability of a subject with the target condition 
having a positive test result divided by the probability of an individual without the target 
condition having a positive test result (Akobeng, 2005).  LR+ = sensitivity/(1 – 
specificity) (Portney & Watkins, 2009). 
5.  Negative Likelihood Ratio (LR-): The probability of a subject with the target 
condition having a negative test result divided by the probability of an individual without 
the target condition having a negative test result (Akobeng, 2005).  LR- = (1 – 
specificity)/specificity (Portney & Watkins, 2009). 
6.  Diagnostic Odds Ratio (DOR): An index which summarizes a test’s accuracy as a 
single number that expresses how many times greater the odds are of finding a positive 
test result in an injured versus a non-injured person.  DOR = positive likelihood 
ratio/negative likelihood ratio = (sensitivity x specificity)/(1- sensitivity) x  
(1-specificity) (Glas, Lijmer, Prins, Bonsel, & Bossuyt, 2003; Macaskill, Gatsonis, 
Deeks, Harbord, & Takwoingi, 2010).  
7.  Prevalence: The number of target conditions in proportion to the total sample size at a 
given time.  Prevalence = (a+c)/(a+b+c+d) (Portney & Watkins, 2009). 
8.  Pre-test Probability: The probability that a target condition exists prior to performing a 
diagnostic test.  Pre-test Probability is equal to the target condition’s prevalence (Portney 
& Watkins, 2009). 
9.  Pre-test Odds: The odds that the patient has the target condition before a diagnostic 
test is performed.  Pre-test Odds = (pre-test probability)/(1 – pre-test probability) 
(CEBM, 2012). 
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10.  Post-test Odds: The odds that the patient has the target condition after a diagnostic 
test is performed (pre-test odds x likelihood ratio) (CEBM, 2012). 
11.  Post-test Probability: The proportion of patients with a target condition after 
performing a diagnostic test.  Post-test Probability = (post-test odds)/(post-test odds +1) 
(Portney & Watkins, 2009). 
12.  Diagnostic Utility: The discriminative potential of a diagnostic test to identify a 
target condition based on measures of sensitivity, specificity, and likelihood ratios. 
Limitations and Assumptions 
1.  All participants provided honest and accurate health and injury information. 
2.  All participants performed at their maximum effort during functional performance 
testing. 
3.  The findings of this study are limited to the tested cohort. 
4.  Injury status was established from a self-reported history of injury question as part of 
the KJOC-SES instrument.  The reporting of a diagnosed injury to the shoulder or elbow 
did not provide information about the time of sustaining an UE SRI. 
Delimitations 
1.  The results of this dissertation are limited to the retrospectively tested cohort and 
cannot be generalized to a broader population or other UE sports. 
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CHAPTER II 
 
REVIEW OF LITURATURE 
 
 
The purpose of this review is to provide supporting information and a framework 
for a clinical prediction model (CPM) of upper-extremity (UE) sports related injury (SRI) 
in college baseball players.  This model will be developed and assessed by examining 
select self-reported outcome measures, sport performance risk factors, and functional 
performance measures (FPMs).  This review of literature will encompass the following: 
(a) evidence-based practice (EBP), (b) CPMs, (c) self-reported injury risk factors, (d) 
sport performance injury risk factors, (e) functional performance injury risk factors, and 
(f) UE SRI related to baseball. 
Evidence-Based Practice 
The EBP paradigm encapsulates a broad spectrum of topics related to the field of 
medicine. A full review of the paradigm has been presented in a number of seminal 
works (Guyatt et al., 2008; Sackett et al., 1997).  EBP concepts recently have become a 
point of emphasis in athletic training professional practice (BOC, 2010; NATA, 2010).  
Coinciding with this, educational reform in entry-level athletic training education has 
established competencies related to EBP knowledge and skills (NATA, 2011).  Although 
EBP may seem new within athletic training professional practice and education, the 
concepts have been well established in other healthcare professions for over 25 years 
(AMA, 2002; Guyatt et al., 2008; Sackett et al., 1997).  The lag in athletic training’s use
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of EBP was formally recognized in 2004 (Hootman, 2004).  Initiatives by the National 
Athletic Trainers’ Association (NATA) and Board of Certification (BOC) have raised 
awareness of the importance of EBP; however, advances in evidence–based (EB) clinical 
research are still lacking in the field.  Specifically there is a need for EB research models 
(Hawk et al., 1998; Sauers & Snyder, 2011) which advance patient–oriented clinical 
practice (Snyder et al., 2008; Valovich McLeod et al., 2008). 
With respect to this dissertation, primary importance lies in the EBP concepts 
related to clinical measures and diagnostic test accuracy.  The overlap between EBP 
concepts and Bayesian statistical inference is central in approaching diagnostic questions 
in the context of clinical practice (Hawkins, 2005).  Specifically, two-by-two (2x2) 
contingency tables provide the foundation for determining the statistical measures of 
validity (Jewell, 2011; Portney & Watkins, 2009) and testing the significance for 
categorical frequency (Norman & Streiner, 2008).  See Table 1 for an example of a 2x2 
contingency table for diagnostic test results. 
Traditionally, 2x2 contingency tables are constructed based on a known reference 
standard and a clinical diagnostic test (Norman & Streiner, 2008; Portney & Watkins, 
2009).  A reference standard is usually based on a “gold standard” in the context of the 
presenting clinical question or target condition.  In the absence of a gold standard, 
Bayesian statistical models can also be constructed based on norm or criterion reference 
variables (Jewell, 2011).  A clear or true reference standard may not be obtainable in 
approaching some clinical questions, in which case, dichotomous patient data may serve 
as a reference criterion standard (e.g., “prior  injury” versus “no prior injury”) (Portney & 
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Watkins, 2009).  The clinical diagnostic test used in constructing a 2x2 contingency table 
can encompass a broad range of procedures (e.g., orthopedic special tests, x-ray results, 
lab work, etc.) but may include any variable with a statistical relationship to the target 
condition.  This allows for the inclusion of unique variables such as self-reported 
outcome measures, sport performance risk factors, and FPMs as screening or clinical 
diagnostic tools (Portney & Watkins, 2009). 
A 2x2 contingency table provides a means of charting a diagnostic test’s four 
possible outcomes: (a) true positive, (b) true negative, (c) false positive, and (d) false 
negative (Portney & Watkins, 2009).  A true positive test result occurs when a diagnostic 
test correctly identifies the target condition.  For a true negative, a diagnostic test 
correctly rules out a target condition.  A false positive occurs when a diagnostic test is 
positive in the absence of the target condition.  Finally, a false negative response is when 
the clinical test is negative in the presence of the target condition.  Once these values 
have been tabulated, the validity of a diagnostic test can be expressed in terms of 
sensitivity (Sn) and specificity (Sp) (Portney & Watkins, 2009). 
Sn and Sp are measures of validity for diagnostic tests and are valuable decision-
making tools in EBP (Portney & Watkins, 2009).  Sn is classically defined as the 
proportion of patients with a positive test result among those with the target condition 
(Guyatt et al., 2008; Sackett et al., 1997; Wagenmakers et al., 2008); Sn = (a/(a + c) 
(Portney & Watkins, 2009).  Sp is defined as the proportion of patients without the target 
condition who will have a negative test result (Guyatt et al., 2008; Sackett et al., 1997; 
Wagenmakers et al., 2008); Sp = (d/(b + d) (Portney & Watkins, 2009).  More simply 
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stated, Sn is the true positive rate while Sp is the true negative rate (Portney & Watkins, 
2009). 
The clinical utility of Sn and Sp may be counterintuitive in clinical practice.  
Diagnostic tests with high Sn are useful at identifying people with a target condition and 
have a very low false negative rate (Jewell, 2011).  Thus, a negative test result is 
beneficial in ruling out the presence of the target disorder.  By contrast, diagnostic tests 
with high Sp are useful at identifying people without the target condition and yield very 
low false positive rates (Jewell, 2011).  Subsequently, a positive test result is beneficial in 
ruling in the presence of the target disorder. 
In addition to Sn and Sp, positive predictive value (PPV) and negative predictive 
value (NPV) are measures of probability that are also derived from a 2x2 table (Akobeng, 
2007a; Portney & Watkins, 2009).  PPV is the proportion of people with a positive test 
who have the target condition. PPV is considered the post-test probability of a target 
condition given a positive test (Akobeng, 2007a).  PPV = a/(a +b) (Portney & Watkins, 
2009).  NPV is the proportion of people with a negative test that do not have the target 
condition; it is considered the post-test probability of not having the target condition 
given a negative test (Akobeng, 2007a).  NPV = d/(c +d) (Portney & Watkins, 2009).  
PPV and NPV depend upon the prevalence of the target condition represented in the 2x2 
contingency table data (Jewell, 2011; Portney & Watkins, 2009).  Prevalence in the 
context of a small sample size may not be a true reflection of the prevalence for a larger 
population (Portney & Watkins, 2009).  Consequently, prevalence may fluctuate 
naturally over time because of the influence of prevention or treatment strategies (Jewell, 
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2011; Portney & Watkins, 2009).  Because PPV and NPV vary with changes in 
prevalence (Akobeng, 2007a), these measures are not considered useful for determining 
diagnostic test validity in clinical practice (Jewell, 2011). 
An alternative to measures of PPV and NPV is the measure of probability through 
likelihood ratios (LR) (Portney & Watkins, 2009).  LR can be calculated directly from a 
2x2 contingent table; however, in the absences of 2x2 table, LR also can be derived 
mathematically from reported Sn and Sp values (Akobeng, 2007b; Portney & Watkins, 
2009).  LR is directionally expressed as positive likelihood ratio (LR+) or negative 
likelihood ratio (LR-).  LR+ is the probability of a subject with the target condition 
having a positive result divided by the probability of an individual without the target 
condition having a positive result (Akobeng, 2005; Portney & Watkins, 2009);  LR+ = 
sensitivity/(1 – specificity) (Portney & Watkins, 2009).  Conversely, LR- is the 
probability of a subject with the target condition having a negative test result divided by 
the probability of an individual without the target condition having a negative test 
(Akobeng, 2005); LR- = (1 – sensitivity)/specificity (Portney & Watkins, 2009).  
Clinically, LR+ indicates how many more times likely a positive test result will be found 
in individuals with the target condition compared to those without the respective 
condition.  LR- indicates how many more times likely a negative test result will be found 
in individuals with the target condition compared to those without the respective 
condition.  Simply stated, a higher LR+ suggests a greater probability of a target 
condition while a lower LR- suggests a lower probability of a target condition. 
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LRs provide three distinct advantages over Sn, Sp, PPV, and NPV measures in 
determining the probability of a target condition.  First, LRs are independent of disease 
prevalence (Akobeng, 2007b; Jewell, 2011; Portney & Watkins, 2009).  Second, LRs can 
be applied to individual patient cases whereas Sn, Sp, PPV, and NPV are group (data set) 
specific (Jewell, 2011; Portney & Watkins, 2009).  Third, LRs are relevant across the 
spectrum of test results irrespective of a positive or negative finding (Jewell, 2011).  
These three factors highlight the clinical utility of LRs in understanding and applying 
diagnostic test results in clinical practice (Akobeng, 2007b). 
The LR+ and LR- are interpreted based on scales of clinical importance (Portney 
& Watkins, 2009) or through use of Fagan’s (Bayesian’s) nomogram (Akobeng, 2007b; 
Guyatt et al., 2008).  Using the clinically important LR scales enables a clinician to 
estimate the probability of the target condition being present.  See Figure 1 for likelihood 
ratio scale of clinical importance and Table 2 for likelihood ratio interpretation guide. 
 
LR- 
 
LR+ 
0 – 0.1 0.1 – 0.2 0.2 – 0.5 0.5 - 2 2 - 5 5 -10 > 10 
important   unimportant   important  
Figure 1. Likelihood Ratio Scale of Clinical Importance. 
Adapted from Portney & Watkins (2009). 
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Table 2. Likelihood Ratio Interpretation Guide 
LR- Shift in Probability LR+ 
< 0.1 large, conclusive > 10 
0.1 to 0.2 moderate, important 5 to 10 
0.5 to 0.2 small, but sometimes important 2 to 5 
0.5 to 1 very small, clinically irrelevant 1 to 2 
Note. Adapted from C. E. Cook & Hegedus (2013), Glynn & Weisbach (2011), and 
Guyatt et al. (2008). 
 
 
Probability estimation occurs pragmatically in the dynamic context of an 
individual patient case.  For example, after taking a patient history, a clinician begins to 
formulate a preliminary working diagnosis.  This hypothesized diagnosis can beformulate 
a preliminary working diagnosis.  This hypothesized diagnosis can be confirmed or 
excluded through selective applications of diagnostic tests.  Diagnostic test selection is 
usually based on clinical estimation of the patient’s probability of having a target 
condition before an actual test result is known (referred to as pre-test probability) 
(Akobeng, 2007b).  Pre-test probability of a target condition may be based on reported 
prevalence in literature, preliminary clinical exam findings, or a “best guess” based on 
clinical experience (heuristics) (Akobeng, 2007b; Portney & Watkins, 2009).  By 
combining pre-test probability and the LR of a diagnostic test, a clinician can determine 
the post-test probability of a patient having the respective target condition.  Specifically, 
a positive test result increases the post-test probability that the patient has the target 
condition while a negative test result implies the opposite.  This relationship is expressed 
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through Bayes’ theorem: post-test odds = pre-test odds x likelihood ratio (Akobeng, 
2007b; Portney & Watkins, 2009).  The mathematical calculation of Bayes’ theorem has 
been simplified and represented in Fagan’s nomogram to facilitate the use of LR in 
clinical practice.  See Figure 2 for Fagan’s nomogram. 
In the case of continuous scale test results, the calculation of Sn and Sp can be 
determined from a receiver operating characteristic (ROC) curve (Akobeng, 2007c; 
Portney & Watkins, 2009).  See Figure 3 for an example of an ROC Curve.  An ROC 
curve is a graphic plot of the Sn and 1-Sp for continuous test values.  The data point 
closest to the upper-left hand corner or at the inflection point of the curve of the ROC 
curve represents the best balance between true positive and false positive tests (Porney & 
Watkins, 2009).  This data point may serve as a cutoff score for discriminating between 
individuals with and without the target condition.  By determining a cutoff score, the 
diagnostic utility (e.g., Sn, Sp, LR+, LR-, and diagnostic odds ratio [DOR]) of test results 
can be calculated appropriately.  ROC curves have three benefits in this respect: (a) 
determining a cutoff score for optimal Sn and Sp, (b) assessing the diagnostic utility of a 
test, and (c) comparing the usefulness of two or more combined tests (Akobeng, 2007c).  
It is important to recognize that ROC curves serve as a decision-making guide in 
balancing the Sn and Sp of a diagnostic test (Portney & Watkins, 2009).    
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Figure 2. Fagan’s Nomogram. 
Taken from Glasziou (2001) and is an adaptation of Fagan’s nomogram for Bayes’ 
theorem (Fagan, 1975).  The nomogram is used by drawing a straight line from the pre-
test probability of the target condition through the likelihood ratio for the diagnostic test 
to the post-test probability. 
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Figure 3. Typical Receiver Operating Characteristic (ROC) Curve. 
The Y axis represents a diagnostic test’s sensitivity; the X axis represents a diagnostics 
test’s one minus specificity (1- specificity) x100; the diagonal center line represents a line 
of non-discrimination where the true positives and the false positives are equal; the 
graphed curve from the origin to the upper right hand corner represents test scores based 
on the relationship between the true positives and the false positives (Jewell, 2011; 
Portney & Watkins, 2009). 
 
 
An optimal cutoff score may be moved subjectively to safeguard against false positive or 
false negative interpretive findings.  This allows a clinician to use a test result as a 
screening tool to stratify a patient based on binary classification (e.g., high or low risk) 
for a target condition. 
DOR may be used to summarize a diagnostic test’s performance characteristics as 
a single number (Glas et al., 2003).  DOR numerically describes how many times greater 
are the odds of a positive test result in a population with the target condition verses those 
without the target condition (CEBM, 2012); DOR = positive likelihood ratio/negative 
likelihood ratio = (sensitivity x specificity)/(1- sensitivity) x (1-specificity) (Glas et al., 
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2003; Macaskill et al., 2010).  DOR values may range from zero to infinity.  Diagnostic 
tests with higher DOR values provide greater discrimination among individuals with and 
without the target condition.  A DOR value ≤1 means that a diagnostic test does not have 
discriminatory power (Glas et al., 2003).  Although a single number as an index of a 
diagnostic test’s performance characteristics may seem beneficial, DOR are not 
appropriate for direct clinical application (CEBM, 2012).  DOR typically are used in 
systematic reviews or meta-analyses but may be of value in comparing or ranking tests 
(Glas et al., 2003).  Collectively, Sn, Sp, PPV, NPV, LR+, LR-, ROC curves, and DOR 
are advanced tools in EBP.  Practitioners should have an understanding of the definitions 
and application of these Bayesian statistics to facilitate diagnostic and prognostic clinical 
decision making (Portney & Watkins, 2009). 
However, in the scope of clinical practice, individual screening or diagnostic tools 
may not be sufficient to identify target conditions in complex patient conditions (Portney 
& Watkins, 2009).  A combination or cluster of factors may be required to enhance 
diagnostic or prognostic utility beyond heuristics (Portney & Watkins, 2009).  Greater 
clarity can be derived from employing more advanced methods to quantify the 
contributions of multiple variables (Norman & Streiner, 2008; Portney & Watkins, 2009; 
Steyerberg, 2010).  CPMs are one viable approach to statistically cluster multiple factors 
and thus enhance diagnostic and prognostic utility (Glynn & Weisbach, 2011; Guyatt et 
al., 2008; Jewell, 2011; Portney & Watkins, 2009). 
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Clinical Prediction Models 
CPMs are statistical models used to estimate probability related to screening, 
diagnosis, prognosis, or treatment interventions (Aronoff et al., 2010; Banks et al., 2010; 
Hicks et al., 2005; Jewell, 2011; Steyerberg, 2010).  Clinically, CPMs are used to identify 
a cluster of predictors to support a diagnostic or prognostic assessment (Portney & 
Watkins, 2009).  The range of predictive factors may include patient history, 
pathophysiology, symptomology, risk factors, test results, and outcome measures 
(Bainbridge et al., 2010; Banks et al., 2010).  The advantage of clustering a set of factors 
in a CPM is to reduce the number of potential factors which strategically guide clinical 
decision-making when approaching complex patient cases (Brasher & Beattie, 2009; 
Bruce & Wilkerson, 2010a). 
A broad range of CPMs exist in sports medicine to facilitate diagnostic and 
prognostic decisions (Glynn & Weisbach, 2011).  The Ottawa Ankle Rule, for example, 
is a diagnostic CPM for determining the necessity of radiograph to rule out a fracture in 
the foot and ankle  (Stiell et al., 1992).  In orthopedic rehabilitation, prognostic CPMs 
have been developed for identifying treatment responsiveness for low back pain  (Cai, 
Pua, & Lim, 2009; Hicks et al., 2005), neck pain (Cai et al., 2009), hip fractures (Steiner, 
Kramer, Eilertsen, & Kowalsky, 1997), spinal manipulation (Childs et al., 2004; Fritz, 
Childs, & Flynn, 2005), and hip osteoarthritis (A. A. Wright, Cook, Baxter, Dockerty, & 
Abbott, 2011; A. A. Wright, Cook, Baxter, Garcia, & Abbott, 2010; A. A. Wright, Cook, 
Flynn, Baxter, & Abbott, 2011).  More recently, CPMs are being developed in athletic 
populations to identify modifiable risk factors that can be addressed through targeted 
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injury prevention strategies (Bruce & Wilkerson, 2010a, 2010b; Wilkerson, Giles, & 
Seibel, 2012; Wilkerson, 2010). 
The methodological approach to designing CPMs exists along a spectrum of 
quality, validity, and clinical utility (Glynn & Weisbach, 2011; Steyerberg, 2010).  It is 
important to recognize the multiphase approach to establishing a CPM.  CPM 
development has been defined as a three phase process: (a) derivation, (b) validation, and 
(c) impact analysis (Childs et al., 2004; McGinn et al., 2000) or recalibration of the 
model (Steyerberg, 2010). The combination of the research design and degree of 
development defines a hierarchy of evidence for evaluating CPMs (Portney & Watkins, 
2009).   
The first phase in constructing a CPM is the derivation stage.  The derivation 
phase is characterized by identifying a set of preliminary factors related to a specific 
outcome (Portney & Watkins, 2009).  The preliminary factors may be generated from a 
combination of methods such as expert opinion, review of literature, prior research, and 
clinical practice (Childs et al., 2004).  Derivation models are typically constructed in a 
select cohort without a comparison or control group (Glynn & Weisbach, 2011).  Single 
center retrospective cohort design is one of the primary means to initiate the development 
process for a CPM without the constraints of a randomized controlled longitudinal 
prospective study (Steyerberg, 2010).  The derivation process is important in determining 
whether a small set of factors may predict an outcome prior to investing in longitudinal 
prospective validation research designs.  Subsequently, derivation models need further 
development before being applied clinically (Portney & Watkins, 2009).  For this reason, 
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the hierarchy of evidence for prediction models categorizes derivation of CPMs as level 
IV (lowest quality) on the continuum of evidence (Portney & Watkins, 2009). 
Validation is the second stage in developing a CPM.  This stage is a critical step in 
authenticating predictor variables in a new cohort (Glynn & Weisbach, 2011).  The 
validation process encompasses an extensive range of methodological approaches 
(Steyerberg, 2010); see Table 3.  Practically, the approach to validating CPMs occurs in 
prospective cohorts or randomized controlled trials (Glynn & Weisbach, 2011).  When 
validated in small prospective samples, CPMs are classified as level III on the hierarchy 
of evidence for prediction models.  Table 4 provides an overview of the hierarchy of 
evidence for evaluating CPMs.  Such CPMs can be applied only in similar patient groups 
and may have limited clinical application (Portney & Watkins, 2009).  Level II CPMs 
have been validated in a broader spectrum of patients or multiple settings, have 
demonstrated accuracy, and have been found appropriate for clinical application (Portney 
& Watkins, 2009). 
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Table 3. Methodological Approaches for CPM Validation 
Large scale retrospective
a
 
New cohort of clinicians
b
 
New patient sample
 b
 
Prospective cohort 
b
 
Cohort study for prognosis
 a
 
One narrow prospective sample
c 
Case-control
 a
 
Case-series
 a
 
Nested case-control
a
 
Cross-sectional
 a
 
Multiple small center prospective sample
 c
 
One center large broad spectrum prospective sample of new patients
 c
 
One center large broad spectrum prospective sample of new clinicians
 c
  
One center large broad spectrum prospective sample of new patients and clinicians
 c
  
Randomized clinical trial
 b
 
Multivariate modeling
 a
 
Predictors and outcomes modeling
 a
 
Note. a Steyerberg (2010). b Glynn & Weisbach (2011). 
c 
Guyatt et al. (2008). 
 
 
Table 4. Hierarchy of Evidence for CPMs 
Level Type of Evidence Clinical Application 
I  Model has been validated in a large 
prospective patient population AND 
one impact analysis study has been 
performed demonstrating improved 
outcomes and/or benefit. 
 
Model can be accurately used to change 
clinician behavior or patient outcomes in 
a wide spectrum of clinical settings. 
II Model has been validated in a large 
scale prospective study with a broad 
spectrum of patients and/or clinicians 
OR the model has been validated in 
multiple diverse setting. 
 
Model can be accurately used in a wide 
spectrum of clinical settings. 
II Prospectively validated in narrow 
sample. 
Model may only be applied in patient 
populations similar to study’s 
prospective sample. 
 
IV Preliminary or derivation models based 
on retrospective design, statistical 
modeling, or single center split sample. 
Model needs to be validated before being 
generalized beyond sample; lacks 
clinical utility. 
Note.  Adapted from Portney & Watkins (2009).  
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The third phase in developing CPMs relates to impact analysis (Childs & Cleland, 
2006; Glynn & Weisbach, 2011; Guyatt et al., 2008; Portney & Watkins, 2009) or model 
recalibration (Steyerberg, 2010).  Impact analysis is intended to determine how a CPM 
influences clinical practice specific to changed behavior, modified decision making, or 
improved outcomes (Guyatt et al., 2008).  Recalibration refers to a process of adjusting a 
predictive model based on how a CPM performs clinically.  Advances in diagnostic 
procedures, changes in patient populations, changes in treatment strategies, or other 
factors may influence the characteristics of a CPM and necessitate recalibration or 
versioning of predictor or outcome variables (Glynn & Weisbach, 2011; Steyerberg, 
2010).  The concepts of impact analysis and recalibration are variations of validation 
procedures and entail prospective research design.  CPMs that use validation based on 
impact analysis or recalibration are classified as Level I on the hierarchy of evidence for 
prediction models (Portney & Watkins, 2009). 
CPMs are commonly used in sports medicine (Glynn & Weisbach, 2011) and are 
applicable to athletic training practice.  As a decision-making tool, CPMs have potential 
to assist in diagnosis, prognosis, and treatment strategies.  This is particularly relevant in 
the context of complex patient groups or injury patterns encountered in clinical practice.  
Collegiate baseball players are one such specialized patient group and often present with 
complex UE injury patterns.  The diagnosis, prognosis, and treatment of UE SRI in 
collegiate baseball players is complex.  Consequently, there is a need to improve the 
decision-making process to assist clinicians in improving patient outcomes.  A CPM of 
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UE SRI would be an important advancement in assisting clinicians in navigating the 
complexities of this patient population. 
We have been unable to locate a CPM specific to UE SRI in baseball in the 
present literature.  However, a prospective derivation prediction model for UE overuse 
injury in Division I softball players (n = 35) has been described (Bruce & Wilkerson, 
2010b).  Although softball and baseball are both UE throwing sports, the mechanics of 
underhand windmill pitching (Oliver, Plummer, & Keeley, 2011; Werner et al., 2005; 
Werner, Jones, Guido, & Brunet, 2006) and overhand pitching (Fleisig et al., 1996) 
motions are distinctly different.  Furthermore, the epidemiologies associated with 
collegiate softball and baseball injuries are distinctly different (Dick et al., 2007; 
Marshall, Hamstra-Wright, Dick, Grove, & Agel, 2007).  Collectively this indicates that 
the prediction model specific to collegiate softball should not be applied to collegiate 
baseball; thus there remains a need for development of a CPM for UE SRI in baseball. 
Predictive Factors of a Preliminary CPM 
As stated earlier, generating a list of predictive factors related to a specified 
outcome parameter is the initial step in creating a CPM (Childs et al., 2004).  A well-
constructed CPM is predicated on predictor factors having a strong relationship with the 
outcome measure (Glynn & Weisbach, 2011; Steyerberg, 2010).  The rationale for 
selecting predictor factors should be supported through review of literature, expert 
opinion, or a conceptual framework (GH Guyatt, Bombardier, & Tugwell, 1986; Streiner 
& Norman, 2008).  The task of identifying potential predictor factors in a derivation stage 
of model development may stem from expert brainstorming (Childs et al., 2004) or a 
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pragmatic approach of choosing available factors present in clinical practice (Steyerberg, 
2010).  A researcher must review available data and make judgments on the feasibility of 
potential factors (Streiner & Norman, 2008).  In the context of a single-center 
retrospective cohort design, the availability and completeness of predictors may be 
limited to available data (Steyerberg, 2010).  Predictor factors collected clinically often 
include demographics, patient history, comorbidity(s), physical exam findings, self-report 
measures of health status and quality of life, basic laboratory tests, or physical functional 
status (Beattie & Nelson, 2006; Falk & Fahey, 2009; Glynn & Weisbach, 2011; McGinn 
et al., 2000; Steyerberg, 2010).  
A broad range of risk factors has been identified and suggested as causal for UE 
SRI in baseball athletes.  These risk factors include: muscle strength deficits (Brown et 
al., 1988; Yildiz et al., 2006), muscle fatigue (Mullaney et al., 2005), internal and 
external strength imbalance (Lewis & Valentine, 2007), glenohumeral internal rotation 
deficit (GIRD) (Borsa et al., 2006; Dines et al., 2009; Wilk et al., 2010), scapula 
dyskinesis (Cooper et al., 2002; Kibler & McMullen, 2003), maximum pitch velocity 
(Bushnell et al., 2010), pitching volume (Fleisig et al., 2010; Olsen et al., 2006), pitch 
type (e.g. slider , curveball) (Escamilla et al., 1998; Fleisig et al., 2010; Fleisig et al., 
2006), playing position (Fleisig et al., 2010; Olsen et al., 2006), throwing biomechanics 
(Fleisig et al., 1995; Fleisig et al., 1996), and low self-reported functional assessment 
measures (Alberta et al., 2010; Domb et al., 2010; Neuman et al., 2011).  These risk 
factors can be conceptually categorized into three areas: (a) self-reported outcome scores, 
(b) sport performance factors, and (c) FPMs. 
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Self-Reported Outcome Measures 
Self-reported outcome measures are a branch of a broader field related to health 
measurement scales (Streiner & Norman, 2008).  Health measurement scales originated 
as a means to quantify psychometric parameters in the social sciences (DeVellis, 2003).  
The use of health measurement scales is well represented in a broad spectrum of sports 
medicine literature (Suk, Hanson, Norvell, & Helfet, 2009) and clinical practice settings 
(Streiner & Norman, 2008).  Health measurement scales traditionally have been classified 
under one of the following: (a) general health, (b) disease specific pathology, (c) regional 
specific, (d) dimension specific, and (e) summary items (Valovich McLeod et al., 2008; 
R. W. Wright & Baumgarten, 2010).  The selection of a particular health measurement 
scale should appropriately match the patient population or presenting medical condition 
(Streiner & Norman, 2008; Suk et al., 2009).  
Within orthopedic medicine, between 30 and 50 musculoskeletal outcome 
measures and instruments related to the shoulder have been reported (Suk et al., 2009; R. 
W. Wright & Baumgarten, 2010).  Wright and Baumgartner (2010) identified ten 
shoulder outcome measures appropriate for clinical practice (see Table 5 - Common 
Shoulder Outcome Measures, for an overview).  Despite the number of available UE 
specific outcome measures, no validated self-report instrument to measure functional 
status of the upper extremity in the overhead athlete was reported until recently (Alberta 
et al., 2010; Domb et al., 2010; Neri, ElAttrache, Owsley, Mohr, & Yocum, 2010; 
Neuman et al., 2011; Sauers et al., 2011; Sauers, Thigpen, Huxel, & Bay, 2009).   
 
 
 
 
3
0 
Table 5. Common Self-Reported Shoulder Outcome Measures 
Study Shoulder Outcome Measure Primary Validation 
Sport Related 
Items
a
 
Scope of Baseball 
Related item 
Michener et al., (2002) 
American Shoulder and Elbow 
Surgeons (ASES) Standardized 
Shoulder Assessment Form 
Middle aged males 2 (10) 
Throw a ball 
overhand; do usual 
sports 
Constant & Murley, 
(1987) 
Constant Middle aged males 1 (8) Recreation/sport 
Hudak, et al., (1996) 
Disabilities of the Arm, Shoulder 
and Hand (DASH) questionnaire 
General population; middle 
aged 
4 (34) 
Sports and 
performing arts 
module 
Alberta et al. (2010) 
Kerlan-Jobe Orthopaedic Clinic 
overhead athlete shoulder and 
elbow score (KJOC-SES) 
Collegiate overhead 
athletes,  
10 (10) Sport specific 
Dawson et al. (1999) 
Oxford Shoulder Instability 
Score 
Individuals with SH 
instability 
1 (12) 
Sporting activities & 
hobbies 
Beaton et al. (2005) Quick DASH 
General population; middle 
aged 
4 (15) 
Sports and 
performing arts 
module 
Hollinshead et al. 
(2000) 
Rotator Cuff Quality-of-Life 
General population; middle 
aged 
4 (34) 
Recreational activity 
and sport 
participation module 
Brophy et al. (2005) Shoulder Activity Level 
General population; middle 
aged 
0 n/a 
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Table 5 (continued) 
Williams et al. (1999) 
Single Assessment Numeric 
Evaluation (SANE) 
Patients who underwent SH 
surgery for impingement or 
AC separation 
0 n/a 
Ellman et al. (1986) UCLA Shoulder Score 
General population, middle 
aged 
0 n/a 
Kirkley et al. (1998). 
Western Ontario Instability 
Index (WOSI) 
General population; middle 
aged 
4 (21) 
Sport, recreation, and 
work module 
Lo et al. (2001) 
Western Ontario Osteoarthritis of 
the Shoulder (WOOS) Index 
General population; middle 
aged 
4 (19) 
Sport, recreation, and 
work module 
Note.  Adapted from Suk et al. (2009) and R. W. Wright & Baumgarten (2010).   
a
Number of sport specific items (total number of items). 
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The Kerlan-Jobe Orthopaedic Clinic overhead athlete shoulder and elbow score (KJOC-SES) 
(Alberta et al., 2010) and the Functional Arm Scale for Throwers© (FAST©) (Sauers, 
Ellery, Snyder, & Bay, 2008; Sauers et al., 2009) are self-report instruments developed 
specifically to measure functional status of the shoulder and elbow in overhead athletes.  
Existing self-report outcome instruments such as the Disabilities of the Arm, Shoulder 
and Hand (DASH) and American Shoulder and Elbow Surgeons (ASES) Standardized 
Shoulder Assessment Form) are limited in their ability to evaluate functional outcomes 
(Alberta et al., 2010) or health related quality of life (HRQOL) (Sauers et al., 2011) in 
overhead athletes.  The DASH and ASES instruments do not have items to measure 
overhead function specific to game and practice conditions.  Furthermore, the common 
shoulder outcome measures do DASH and ASES instruments do not have items to 
measure overhead function specific to game and practice conditions.  Furthermore, the 
common shoulder outcome measures do not discriminate among sporting activities, 
recreation, and work.  Subsequently, the KJOC-SES and FAST© were developed to 
provide valid and responsive self-report outcome measures specific to the high demands 
of overhead athlete populations (Alberta et al., 2010; Sauers et al., 2008). 
The KJOC-SES has demonstrated a high correlation to existing shoulder outcome 
measures like the DASH and the ASES, but provides the advantage of correctly 
stratifying functional status in overhead athletes based on UE SRI history (Alberta et al., 
2010) whereas the others do not.  Since its development, the KJOC-SES has been 
validated in subgroups of baseball players who are asymptomatic (Kraeutler et al., 2012), 
have undergone ulnar collateral ligamnet (UCL) recontruction (Domb et al., 2010), type 
 
33 
II superior labral anterior-posterior (SLAP) lesion repairs (Neri et al., 2010; Neuman et 
al., 2011), capsular plication for anterior shoulder instability (Hsu, Gould, Fonseca-
Sabune, & Hausman, 2009), or present with medial elbow pain (Sweitzer et al., 2012).  
The KJOC-SES is reported to be a more sensitive and accurate outcome measure 
compared to the DASH and the ASES in discriminating changes in functional status in 
collegiate overhand athletes (Alberta et al., 2010; Neuman et al., 2011) 
In addition to the KJOC-SES, an alternative self-reported outcome measure specific to 
throwing athletes has recently been reported (Sauers et al., 2011).  Functional Arm Scale 
for Throwers© (FAST©) is a single self-report measure designed to measure health-
related quality of life (HRQOL) based on the five disablement domains: pain, 
impairment, functional limitation, disability, and societal limitation.  The FAST© 
instrument was validated in a cohort of adolescent pitchers (n = 21) and was found to 
better discriminate between those with and without positive pain and histories of UE SRI 
compared to the DASH (Sauers et al., 2009).  Subsequently, FAST© has been validated 
as a regional specific self-report measure in a cohort (n = 25) high school and college 
softball pitchers (Sauers et al., 2011).  It should be noted that FAST© is a copyright-
protected instrument and to date has not been made available through the literature or 
public domain. 
Incorporating a self-report scale such as the KJOC-SES into clinical research is 
consistent with the EBP because these scales provide patient-specific assessment of 
functional (Reiman & Manske, 2011).  It is important to recognize that self-reported 
outcome measures are not intended to be used in isolation but are part of a 
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comprehensive approach to patient management.  Obtaining a more comprehensive 
clinical picture needs to include a broad spectrum of information to quantify the 
impairment, functional limitations, and disability domains.  In this respect, self-report 
measures can be coupled with sport performance risk factors and FPMs to develop a 
more comprehensive understanding of the relationship between SRI and disablement in 
high functioning athletic populations.  To date there are no known investigations of injury 
risk which incorporate self-reported outcome measures in combination with other risk 
factors in baseball players. 
Sport Performance Risk Factors  
An understanding of injury causation has been suggested to be a cornerstone of 
SRI prevention (Bahr & Krosshaug, 2005).  Identifying risk factors, which may 
predispose an athlete to SRI, can be delineated as intrinsic (e.g., age, gender, anatomy) or 
extrinsic (e.g., injury exposure rates, environmental conditions, sport performance 
variables) (Bahr & Krosshaug, 2005).  A range of baseball performance extrinsic injury 
risk factors have been presented (Bradbury & Forman, 2012; Bushnell et al., 2010; 
Fleisig et al., 2010; Olsen et al., 2006).  Baseball injury risk factors commonly have been 
reduced in clinical terms to a nebulous collection of issues such as mechanical flaws, 
excessive pitching, improper strength and conditioning, or improper rest (Ortiz, 2011).  
Reducing these risk factors into broad categories (such as mechanical flaws, and pitching 
volume, strength deficits) without quantified descriptors provides little clarity in 
furthering understanding the relationship between risk factors and UE SRI.  Fortunately, 
evidence has begun to emerge that identifies specific risk factors for shoulder and elbow 
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injuries in baseball players (Bradbury & Forman, 2012; Bushnell et al., 2010; Fleisig et 
al., 2010; Olsen et al., 2006). Understanding this literature is paramount to developing a 
comprehensive CPM for UE SRI in baseball athletes. 
Maximum pitch velocity has been identified anecdotally (Ortiz, 2011) and 
prospectively as a risk factor for elbow injury in professional (Bushnell et al., 2010) and 
for shoulder and elbow injuries in adolescent baseball pitchers (Olsen et al., 2006).  
Anecdotal data have been used to indicate that maximum pitch velocities over 100 mph 
are a risk factor for injury in professional baseball players (Ortiz, 2011).  However, these 
data have not been substantiated in the literature.  The work of Bushnell et al. (2010) in a 
small prospective cohort (n = 23) has been instrumental in describing the association 
between maximum pitch velocity and ulnar collateral ligament injury.  High average 
pitch velocity of 39.88 m/s (89.22 mph) versus low average pitch velocity 38.09 m/s 
(85.22 mph) has been associated with an increased risk of ulnar collateral ligament sprain 
(Bushnell et al., 2010).  The relationship between maximum pitch velocity and risk of 
injury is independent of pitching role (starter versus reliever), games played, innings 
pitched, total pitches thrown, or pitches per game (Bushnell et al., 2010).  A relationship 
may exist among the length of playing career, maximum pitch velocity, and UCL injury 
(Bushnell et al., 2010).  In adolescent aged pitchers, average fastball velocity above 85 
mph has been established as the threshold for increasing injury risk (Olsen et al., 2006).  
It is important to note that the use of maximal or average pitch velocity as a risk factor 
has not been established in high school, or collegiate pitchers.  Incorporating maximum 
or average pitch velocity as a predictive factor thus warrants consideration. 
 
36 
An ROC curve from the Bushnell et al. (2010) data set yields an average velocity 
of 84 mph that may serve as a velocity threshold for increased risk of UE SI.  Hand 
tabulation of a 2x2 contingency table with UCL injury as a reference standard and pitch 
velocity dichotomized as high velocity ( > 84 mph) and low velocity ( 83.9) yields an 
Sn of 0.46, Sp of 0.75, LH+ 1.86 of and LH- 0.71.  This indicates that pitch velocity as a 
single risk factor lacks clinical utility in predicting injury despite the reported statistical 
relationship between pitching velocity and UCL injury.  This may be an initial step in 
establishing velocity as a risk factor; however, the Bushnell et al. (2010) sample size (n = 
23) may limit generalization. 
Pitch type also has commonly been identified as a risk factor for injury (Andrews 
& Fleisig, 1998).  The curveball was believed to increase risk of shoulder pain by 52% 
while the slider has been associated with an 86% increased risk of elbow pain (Lyman, 
Fleisig, Andrews, & Osinski, 2002).  Recent longitudinal prospective analysis has refuted 
the notion that breaking pitches in youth baseball players correlate with shoulder or 
elbow injuries (Fleisig et al., 2010).  This evidence has been substantiated by 
biomechanical analysis that indicates that curveballs do not produce greater kinetic force 
in the shoulder or elbow in collegiate pitchers (Barrentine, Matsuo, Escamilla, Fleisig, & 
Andrews, 1998; Fleisig et al., 2006).  Evidence has not correlated the slider with an 
increased prevalence of injury; however, the pitch produces greater joint torques 
compared to the fastball in mature pitchers (Escamilla et al., 1998).  This evidence 
collectively suggests that pitch type may not be a definitive risk factor of UE SRI in 
baseball pitchers. 
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Pitching volume is another proposed risk factor for UE SRI in youth (Fleisig et 
al., 2010) and professional pitchers (Bradbury & Forman, 2012).  An increased pitching 
volume in youth has been correlated with an increased risk for shoulder and elbow injury 
with a suggested threshold of 100+ innings per season (Fleisig et al., 2010).  Pitching 
volume thresholds have not been specified for high school, collegiate, or professional 
levels.  Recently, cumulative pitching load in combination with decreased rest days has 
been quantified as a negative factor in pitching performance and hypothesized as a 
potential risk factor for UE SRI in professional baseball pitchers (Bradbury & Forman, 
2012).  Bradbury and Forman (2010) suggest that the negative impact of high pitching 
volume may be more likely correlated with a decline in pitching performance (e.g., ERA, 
strike-to-balls ratio, homeruns) versus UE SRI rate.  Additionally, extended pitch counts 
of 150 pitches per game have been found to adversely affect shoulder kinematics, which 
may predispose a collegiate player to increased risk of injury (Kohlmeyer, 2005).  A pitch 
count of 70 pitches per game has been suggested as the threshold for producing 
significant differences in pitching mechanics (Kohlmeyer, 2005); however, a correlation 
with UE SRI has not been established based on this finding.  Collectively, although the 
exact statistical relationship between pitching volume and UE SRI has not been clearly 
established in skeletally mature pitchers, such data warrant further consideration. 
In addition to pitch counts, throwing volume by position has been described in 
collegiate baseball players (Barrett & Burton, 2002).  The number of active (direct game 
play) and inactive (unrelated to direct game play) throws contributes to the collective 
throwing volume sustained in the context game play.  The frequency of observed game 
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play throws by position were reported as follows: pitchers 51%, catchers 29%, infielders 
17% and outfielders 3% (Barrett & Burton, 2002).  These data indicate that throwing 
volume is position specific and that game play throwing volume in combination with 
pitch count predisposes pitchers and catchers to the highest volume of arm related 
throwing stress.  This would account for the increased prevalence of UE SRI specifically 
in pitchers (Dick et al., 2007; Fleisig et al., 1995; Posner et al., 2011).  Furthermore, 
throwing volume by position also accounts for the increased injury rates in multiple 
position players who participate as a starting pitcher and catcher in the same game 
(Fleisig et al., 2010).  The relationship between game-day throwing volume and playing 
position is a risk factor for UE SRI in lower levels of baseball and may be a risk factor 
for multiple-position collegiate players. 
Level of experience has been suggested as another risk factor for UE SRI 
(Chambless, Knudtson, Eck, & Covington, 2000).  Rookie professional baseball players 
sustain a significantly higher injury rate than more experiences players.  The higher 
injury rates are attributed to participating at a high level of play without sufficient time to 
condition and adapt to longer playing seasons and higher competitive demands.  It can be 
posited that a similar relationship may exist when athletes transition from little league to 
high school and from high school to college. 
Collectively, sports performance risk factors can be grouped into five distinct 
categories: (a) game-play exposure, (b) average fastball velocity (pitcher specific), (c) 
throwing volume (pitcher specific), (d) playing experience, and (e) playing position 
(pitcher versus fielder).  Although progress has been made in clarifying sport 
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performance risk factors in adolescent baseball players, additional investigation is needed 
to understand the multifactorial nature of risk factors in relationship to UE SRI in 
baseball.  The influence of these sport performance risk factor categories has not been 
fully considered in collegiate and professional baseball players.  One could suggest that 
these sport performance factors are important in understanding the risk for UE SRI in 
more advanced levels of baseball competition; however, the magnitude of these risk 
factor categories warrants further study. 
Recently, advancements have been made in understanding the risk factors for UE 
SRI in adolescent baseball pitchers.  A 10-year prospective investigation by Fleisig et al. 
(2011) identified a number of important risk factors for serious UE SRI in youth baseball 
pitchers.  Although the investigation is a landmark study, the investigators did not present 
a multifactorial analysis of risk factors nor describe a CPM.  Olsen et al. (2006) 
prospectively developed multivariate logistic regression models of risk factors in 
adolescent baseball pitchers.  The model identifies four factors associated with SRI: (a) 
pitching more than eight months, (b) pitching more than 80 pitchers per game, (c) fastball 
velocity greater than 85 mph, and (d) pitching with arm fatigue (Olsen et al., 2006).  
Despite identifying multiple factors, the model of Olsen et al. (2006) included only 
single-factor statistical analysis and failed to present a single multifactorial model to 
account for a composite of risk factors.  A CPM that identifies a composite of risk factors 
may further our understanding of athletes at risk for significant UE SRI. 
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Functional Performance Measures 
FPMs are physical testing procedures used for the assessment of physical abilities 
(Reiman & Manske, 2011).  Function can be measured through impairment measures 
(e.g., manual muscle testing, joint range of motion), self-report measures (e.g., pain 
scales, DASH, KJOC-SES), and physical performance measures (e.g., muscle endurance 
testing, dynamic balance, jump/hop testing) (Reiman & Manske, 2011).  Reiman and 
Manske (2009) have cataloged approximately 140 individual FPMs which span 10 
parameters: anthropometric; muscle length; fundamental movements; balance; aerobic; 
strength and power; speed, agility, and quickness; trunk; upper extremity; and lower 
extremity (Reiman & Manske, 2009).  Because of the large number of available tests, the 
inclusion of specific FPMs in clinical practice may be confusing for clinicians.  In an 
effort to simplify screening procedures, clusters of tests have been grouped to form 
batteries to quantify the characteristics of function, injury assessment, sport performance, 
and injury prediction in athletic populations (Butler, Plisky, Southers, Scoma, & Kiesel, 
2011; G. Cook et al., 2006a, 2006b; G. Cook et al., 2010; Frohm, Heijne, Kowalski, 
Svensson, & Myklebust, 2011; Kiesel, Plisky, & Butler, 2009; Kiesel et al., 2007; Minick 
et al., 2010; Plisky et al., 2009; Plisky, Rauh, Kaminski, & Underwood, 2006; 
Schneiders, Davidsson, Horman, & Sullivan, 2011).  Using a battery of tests allows for a 
standardized approach to the assessment of function to aid clinical practice and to 
facilitate the long-term study of the reliability and validity of FPMs (Reiman & Manske, 
2011). 
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Individual FPMs traditionally have been classified by discrete physical 
parameters (e.g., balance, strength, power) and/or regional designation (lower-extremity, 
trunk, upper-extremity) (Reiman & Manske, 2009).  More recently a FPMs twelve-level 
classification hierarchy has been proposed to define the assessment levels of function 
(Reiman & Manske, 2011), see Table 6. 
 
Table 6. Classification Hierarchy for the Assessment of Function in Individuals 
Level Description of primary assessment 
I Subjective report (patient or clinician)  
II Impairment 
III Static observation, posture, balance 
IV Dynamic posture, general movement patterns, single plane dynamic balance 
V Movement patterns encountered during high level tasks and/or multi-planar 
dynamic balance 
VI Specific movement patterns 
VII Performance-based measures predominantly in one plane 
VIII Performance-based measures predominantly in one plane, requiring limited base  
of support, multiple joints, multiple muscle groups, or explosive movements 
IX Performance-based measures predominantly in multiple planes and/or requiring  
explosive movement 
X Performance-based measures predominantly in multiple planes and/or requiring  
explosive movement with the quality of performance assessed 
XI Replication of specific tasks performed during individual sports/occupational  
activity or clusters of performance-based measures that replicate 
sports/occupational activity 
XII Cumulative assessment including performance assessment with self-report and  
bi-psycho-social measures 
Note.  Adapted from Reiman & Maske (2011) 
 
 
FPMs exist on a continuum which may use impairment-based measures (e.g., range of 
motion, manual muscle testing, gait), self-report measures, and physical performance 
measures (e.g., muscle endurance tests, movement patterns).  Impairment-based and 
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observation-based (e.g., static posture) assessments of function are classified as lower 
level while multi-plane (e.g., figure-8 hop) or explosive movements (e.g., triple hop for 
distance) are classified as higher level functional assessments.  In general, the closer an 
FPM approximates an actual sport, occupational, or daily activity the higher the 
respective classification rating (Reiman & Manske, 2011).  Reiman and Manske (2011) 
suggest that function should be assessed along a continuum and include multiple 
measures.  An optimal approach for functional assessment in athletic populations should 
incorporate a range of physical parameters and a balance of regional designations across 
several assessment levels.  Such an approach would necessitate transitioning from 
individual tests to a cluster of FPMs to obtain a  
global assessment and a high level of classification. 
FPMs have been clustered to form a battery of tests that incorporate multiple 
discrete parameters and regional designations to derive a global assessment measure of 
function (G. Cook et al., 2006a, 2006b; Frohm et al., 2011; Hegedus, 2011; Kiesel et al., 
2009).  The most noted FPM batteries are the Functional Movement Screen (FMS) 
(G. Cook et al., 2010) and Frohm’s nine-test screening battery for athletes (Frohm et al., 
2011).  Recently an alternative global battery of tests, the Targeted Enhanced Athletic 
Movement Screen (TEAM-S) has been developed for athletic populations (Hegedus, 
2011).  An overview or comparison of the FMS, Frohm’s nine-test screening battery, 
and TEAM-S is provided in Table 7.    
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Table 7. Comparison of Functional Performance Screening Batteries 
Performance Measure FMS® 
(21 pts) 
FROHM 9-Test 
Screen (27 pts) 
TEAM-S 
(75 pts) 
Beighton Hypermobility    Yes 
Full Squat Yes Yes Yes 
Single Leg Squat  Yes Yes 
Downward Dog    Yes 
Active Straight Leg Raise Yes Yes Yes 
Shoulder Mobility Test  Yes Yes 
Y-Balance for upper-extremity   Yes 
CKCuest   Yes 
Side Plank Hip Abduction   Yes 
Side Plank Hip Adduction    Yes 
Nordic Hamstring Test   Yes 
Triple Hop for Distance   Yes 
Vertical Leap   Yes 
In-line Lunge for Distance  Yes Yes Yes 
Lateral Lung for Distance   Yes 
Qualitative Dyskinesis Screening 
Test
a
 
  Yes 
Push-up Test Yes Yes  
Diagonal Lift Test  Yes  
Straight Leg Raise Test (Passive)  Yes  
Rotary Stability Yes Yes  
Hurdle Sep Yes   
Note.  
a
The Qualitative Dyskinesis Screening Test is not part of the original TEAM-S 
battery of tests and was added for UE athletes. 
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FPMs batteries integrate a variety of measures in an attempt to capture an envelope of 
function central to active populations This is an important consideration in determining 
the relationship between functional or athletic performance and injury risk (Reiman & 
Manske, 2011). 
The FMS is a commercialized functional assessment system comprised of a 
seven item battery intended to identify functional imbalances thought to affect 
performance and prevent injury (G. Cook et al., 2010).  The maximum score for the 
FMS
TM
 is 21 points.  Each individual FPM item is subjectively scored on a 4-point scale 
(0-1-2-3): 0 if pain present; 1 = movement pattern is incomplete or not performed 
consistent with the FMS definition; 2 = movement pattern demonstrates compensation, 
faulty form, or loss of alignment consistent with the FMS definition; 3 = movement 
pattern is complete and consistent with FMS definition (G. Cook et al., 2010).  It is 
important to note that the original text describing the FMS
TM
 did not report reliability or 
validity despite claims of its clinical utility for improving performance and injuryvalidity 
despite claims of its clinical utility for improving performance and injury prevention (G. 
Cook et al., 2010).  Recent studies have reported normative values of the FMS
TM
 in 
young active populations (15.7, 95% CI [15.4-15.9]) (Schneiders et al., 2011), 
professional football athletes (16.9±3.0) (Kiesel et al., 2007), and active military service 
members (15.7±0.2) (Teyhen et al., 2012).  Individual item reliability (kappa) has been 
reported to range from 0.73 to 1.00 (Schneiders et al., 2011), while total score reliability 
(ICC) has ranged from 0.74 (Teyhen et al., 2012) to 0.92 (Minick et al., 2010). 
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The validity of the FMS to predict injury is disputed.  Kiesel et al. (2007) reported a 
cutoff score equal to or less than 14 was predictive of serious injury (Sp of 0.91, Sn of 
0.54, LR+ of 5.92, and a LR- of 0.51) in a cohort (n = 46) of professional football 
players.  Based on these original data, a cutoff score of 14 correctly identified 53.8% (7 
of 13) of the injury cases.  In contrast, Teyhen et al. (2012) reported that an FMS
TM
 cutoff 
score of ≤ 14 identified correctly only 15.6% of the injury cases in a cohort (n = 64) of 
active military service members.  The discrepancy in correctly identifying injury calls 
into question the validity of the FMS
TM
 as a viable screening tool and highlights the need 
for additional and larger longitudinal investigations to determine the screen’s 
psychometric properties (Teyhen et al., 2012). 
The Frohm nine-test screening battery was developed over a 5 to 10-year period 
of clinical practice by selectively combining items from the FMS and the United States 
Tennis Association High-Performance Profile screening system (Frohm et al., 2011).  
Each test item is subjectively scored on a four point scale (0-1-2-3); 0 if pain is present; 1 
= not correct despite compensatory movement; 2 = correct but with compensatory 
movement; 3 = correct without compensatory movement.  The normative composite 
score in healthy elite male soccer athletes was established between 18.3 (95%CI [14.9-
21.7]) and 18.0 (95%CI [14.4-21.7]) with a test-retest reliability of ICC of 0.81 to 0.80 
(Frohm et al., 2011).  Normative and reliability values were based on a small cohort (n = 
26) of healthy elite level male soccer players (Frohm et al., 2011) and may not be 
generalized to other populations.  Frohm et al. (2011) suggested that the screening battery 
may be limited in clinical utility because it has not been validated for injury prevention, 
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rehabilitation, or performance enhancement.  Aside from the original investigation, we 
were unable to locate other references of the Frohm nine-test screening battery in the 
literature. 
Hegedus (2011) developed and proposed the TEAM-S as an alternative to the 
commercialization of a functional performance screening system and to develop a 
screening battery consistent with EBP.  The individual test items that comprise the 
TEAM-S originally were selected based on 20 years of physical therapy clinical 
experience with functional performance screening in a broad spectrum of healthy and 
injured recreational, high school, collegiate, and professional athletes (E. J. Hegedus, 
personal communication).  Individual TEAM-S items were selected based on providing a 
mixture of upper-extremity, trunk, and lower-extremity functional measures to reflect a 
composite of functional screens related to sports activity.  Most importantly, individual 
TEAM-S items have established reliability measures reported in the literature; see Table 
8.  Each TEAM-S item is scored on a 6 point rating scale (0-1-2-3-4-5) with a maximum 
score of 75 points.  Unlike the FMS
TM
 or the Frohm nine-test screen, the scoring of a 
TEAM-S item is based upon a combination of subjective scoring criteria and objective 
measurements.  Appendix B is the TEAM-S score sheet and provides a description of 
each test and its respective scoring criteria.  The psychometric properties of the TEAM-S 
are currently under investigation in an international multicenter research project.  The 
global reliability and validity of TEAM-S and has not been reported in literature.   
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Table 8. TEAM-S Functional Performance Measures Including Assessment Level and 
Previously Reported Reliability 
 
Functional Performance 
Measures 
Assessment 
Level
1
 
Reliability 
Beighton Hypermobility  II ICC = 0.98-0.96 
8
 
Full Squat VII Inter, kw = 0.68, Intra, kw = 0.76 
4 
Inter ICC = 0.73 
10
 
Single Leg Squat VII Inter, k = 0.8-0.6, Intra, k = 0.8-0.613 
2 
Inter, k = 0.99, Intra, k = 0.98-0.88 
7 
Inter ICC = 0.53 
10
 
Downward Dog  III none reported 
Active Straight Leg Raise II Inter, kw = 0.69. Intra, kw = 0.60 
4 
ICC = 0.94-0.99 
6 
Inter ICC = 0.64 
10
 
Shoulder Mobility Test II Inter, kw = 0.73, Intra, kw = 0.68 
4
   
Inter ICC = 0.85 
10
 
Y-Balance for upper-extremity VIII Test-retest ICC = 0.99 -0.80, Inter ICC = 
1.00 
12 
CKCuest VIII ICC = 0.99 
11 
Side Plank Hip Abduction VII Inter, ICC = 0.70 – 0.59, Intra, ICC = 
0.74
3
 
Side Plank Hip Adduction  VII none reported 
Nordic Hamstring Test VII Inter, k = 0.24 
15 
Triple Hop for Distance IX ICC = 0.97 
13 
Vertical Leap VIII Males, ICC =  0.94, Females, ICC = 0.87-
0.89 
5 
In-line Lunge for Distance  VII Inter, kw = 0.45, Intra, kw = 0.69 
4 
Inter ICC = 0.75 
10 
Intra ICC = 0.96 
13 
Lateral Lung for Distance VII Intra ICC = 0.96 
14 
Qualitative Dyskinesis* VII kw = .061-0.48 
Note. ICC = Interclass correlation; K = kappa; kw = weighted kappa; NR = not reported. 
1
 
Raimen & Manske (2011); 
2
 Crossley et al. (2011); 
3
 Davis et al. (2011); 
4
 Teyhen et al. 
(2011); 
5
 Nuzo et al. (2011); 
6
 Askling et al. (2010); 
7
 Poulsen & James  (2011); 
8
 Evans 
et al. (2012); 
9
 McClure et al. (2012); 
10
 Frohm et al. (2011); 
11
 Goldbeck & Davies 
(2000); 
12
 Gorman et al. (2012); 
13
 Ross et al. (2002); 
14
 Crill et al. (2004); 
15 
Engebretsen 
et al. (2010)  
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In the context of this dissertation, developing a CPM for UE SRI in college baseball 
players that incorporates the TEAM-S would be a valuable contribution in establishing 
the instrument’s validity in the area of injury prediction. 
The assessment of function limitations at the level of the whole person has gained 
increased importance in athletic populations (Reiman & Manske, 2011).  The screening 
of dysfunctional movement patterns prior to the onset of pain, functional limitations, or 
injury is an important consideration (Arnason, Tenga, Engebretsen, & Bahr, 2004).  
Functional screening tools that are sensitive to functional limitations and asymmetry are 
needed in clinical practice (Bahr, 2009).  The FMS, Frohm’s nine-test screening 
battery, and TEAM-S are viable functional performance screens for quantifying the 
characteristics of function, injury assessment, sport performance, and injury prediction in 
athletic populations.  However, determining which combination of functional assessment 
measures best assesses injury risk requires further investigation (Reiman & Manske, 
2011).  Specifically, the relationship between functional movement screens and injury 
should be investigated in combination with self-report measures and risk factors (Reiman 
& Manske, 2011). 
Baseball UE SRI Epidemiology 
Differing injury rates and incidences have been reported for youth, high school, 
collegiate and professional baseball levels (Comstock, Collins, & McIlvain, 2011; Dick et 
al., 2007; Hootman et al., 2007; Janda, 2003; Kerut et al., 2008; Lyman & Fleisig, 2005; 
Magra et al., 2007; McFarland & Wasik, 1998; Posner et al., 2011).  It has been reported 
that upwards of 164,800 injuries per year are sustained in little league (Pasternack, 
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Veenema, & Callahan, 1996) and 46,700 injuries per year in high school (Comstock et 
al., 2011).  About 440 major league baseball players per year are placed on the disabled 
list.  In comparison to other sports, baseball has a relatively low overall injury rate of 
0.23 per 1,000 athlete exposures (Hootman et al., 2007).  The collegiate and professional 
preseason injury rates (2.87 and 5.73 per 1,000 exposures) have been reported to be 
higher than in-season injuries rates (1.58 and 0.54 per 1,000 exposures) (Dick et al., 
2007; Posner et al., 2011).  Injury rates are about three time higher in games (5.78 per 
1,000 exposures) than practices (1.85 per 1,000 exposures) (Dick et al., 2007).  Despite 
the relatively low injury rates, the incidence of UE SRI for baseball players increases 
with competitive level.  Incidence rates have been reported to be 5% in little league and 
high school (Fleisig et al., 2010), 25% in collegiate (Dick et al., 2007), and 50% in 
professional (Anz et al., 2010) baseball.  The primary injuries of concern (associated with 
extended time loss) are ulnar collateral ligament (UCL) sprains/tears (Cain, Dugas, Wolf, 
& Andrews, 2003; Domb et al., 2010; Jazrawi et al., 2006; Wood, Konin, & Nofsinger, 
2010), superior labrum tears from anterior to posterior (SLAP lesions) (Burkhart & 
Morgan, 1998; Burkhart & Morgan, 2001; Burkhart, Morgan, & Kibler, 2003), rotator 
cuff pathologies (Gerstman, Malanga, & Ferrer, 2009; Jobe & Bradley, 1988; Namdari, 
Baldwin, Ahn, Huffman, & Sennett, 2011; Yanagisawa, Niitsu, Takahashi, & Itai, 2003), 
and impingement syndromes (Burkhart, 2006; Kuhn, 2009).  It has been reported that the 
severity of these injuries has led to a four-fold increase in elbow and a six-fold increase in 
shoulder surgical intervention (Fleisig et al., 2006).  The rise in serious UE SRI in 
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baseball has prompted interest in research focused on identifying risk factors for the 
purpose of injury prevention strategies. 
Conclusion 
Recently, there has been an increase in the prevalence of serious UE SRI in all 
levels of baseball which has sparked increased research interest in identifying injury risk 
factors.  A number of investigations have focused on recognizing potential sport-specific 
injury risk factors but have not approached the issue from an EBP paradigm.  The 
development of a CPM that includes self-reported outcome measures, sport performance 
risk factors, and FPMs would be a critical step in advancing the body of knowledge.  
Furthermore, a CPM based on Bayesian statistics (e.g., Sn, Sp, and LRs) would directly 
assist clinicians in the screening and evaluation of baseball players at risk for UE SRI. 
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CHAPTER III 
 
METHODOLOGY 
 
 
The purpose of this research was to develop and assess a preliminary clinical 
prediction model (CPM) for upper-extremity (UE) sports related injury (SRI) in a 
retrospective cohort of collegiate baseball players.  The research design was a single-
center retrospective cohort study. 
Participants 
In the fall of 2011, 156 Division I athletes from the sports of baseball (n = 37), 
men’s basketball ( n = 10), women’s basketball (n = 15 ), cheerleading (n = 18), men’s 
cross-country (n = 13), women’s cross-country (n = 10 ), men’s track and field (n = 5), 
women’s track and field (n = 7), women’s lacrosse (n = 28), and volleyball (n = 13) 
participated in High Point University’s (HPU) annual pre-participation examination 
(PPE).  An individual from the research team other than this dissertation author provided 
participants with a verbal and written explanation of the research project.  Written 
informed consent was obtained as approved by the HPU Institutional Review Board.  The 
researchers were unaware of who consented until after completion of screening.  Data 
belonging to subjects who did not consent to voluntary participation were excluded 
The HPU PPE consisted of the following: (a) HPU Athletic PPE Form 
New/Transfer Athlete Medical History Form, (b) HPU Waiver for Athletics, (c) National. 
Collegiate Athletic Association (NCAA) HIPAA Form, (d) HPU HIPAA Form, (e) HPU
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Athletic Insurance Policy, (f) HPU Medical Insurance Form, (g) NCAA ADHD/ADD 
Notification Document, and (h) NCAA Sickle Cell Screening Notification Document.  
Following medical clearance by team physicians, athletes completed the Targeted 
Enhanced Athletic Movement Screen (TEAM-S) and sport specific pre-season 
conditioning tests.  In addition, UE athletes (volleyball and baseball) completed the 
Kerlan-Jobe Orthopaedic Clinic overhead athlete shoulder and elbow score (KJOC-SES) 
in conjunction with the TEAM-S.  All testing procedures were standard policy and 
procedure of the HPU intercollegiate athletic department, athletic training department, 
and strength and conditioning program. 
From the 156 tested athletes, thirty-seven Division I baseball players were 
selected (age [yrs] 19.53 ± 0.9; height [cm] 183.3 ± 7.1; weight [kg] 85.6 ± 10.5).  The 
baseball players’ data from the TEAM-S and KJOC-SES were utilized to develop a CPM 
for UE SRI in collegiate baseball players.  One baseball athlete completed the PPE 
process and TEAM-S but did not complete the KJOC-SES.  This subject’s data was 
excluded from data analysis resulting in a final n = 36. 
Instrumentation 
The CPM predictive factors were derived from three domains: (a) self-reported 
outcome measures, (b) sport performance risk factors, and (c) functional performance 
measures (FPMs).  The self-reported outcome measure included the KJOC-SES 
functional assessment tool as described by Albert et al. (2010) (Appendix A).  Sport 
performance risk factors were a range of variables derived from game-play statistics.  
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FPMs were derived from the TEAM-S instrument as presented by Hegedus (2011) (see 
Appendix B).  A more in-depth description of each of these three domain areas follows. 
Self-Reported Outcome Measures 
All participants completed the KJOC-SES (Alberta et al., 2010) (Appendix A).  
The KJOC-SES is a patient-centered, self-report outcome measure specific to overhead 
athletes.  The instrument requests information about UE SRI history, level of 
competition, and contains a 10-item physical functional inventory.  The KJOC-SES UE 
SRI history information for each participant was reviewed and coded by the principal 
investigator as “1” for positive history or “0” for a negative history.  Dichotomizing UE 
SRI history allowed the establishment of a criterion reference for establishing two 
groups: injured and non-injured.  A self-reported UE SRI was operationally defined by 
one or more of the following conditions: ulnar collateral ligament (UCL) sprains/tears 
(Cain et al., 2003; Domb et al., 2010; Jazrawi et al., 2006; Wood et al., 2010), superior 
labrum tears from anterior to posterior (SLAP lesions) (Burkhart & Morgan, 1998; 
Burkhart & Morgan, 2001; Burkhart, Morgan, et al., 2003), rotator cuff pathologies 
(Gerstman et al., 2009; Jobe & Bradley, 1988; Namdari et al., 2011; Yanagisawa et al., 
2003), and impingement syndromes (Burkhart, 2006; Kuhn, 2009). 
Each KJOC-SES physical functional inventory item (e.g., Item 1: “How difficult 
is it for you to get loose or warm prior to competition or practice?”; Item 4: “How 
unstable does your shoulder or elbow feel during competition?”; Item 9: “How much has 
your control (of pitches, serves, strokes, etc.) suffered due to your arm?” was scored on a 
10-cm visual analog scale.  The 10 physical functional inventory items yielded a total 
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score (100 maximum points) as previously described by Alberta et al. (2010).  A Lower 
score represents lesser perceived function. 
Sport Performance Risk Factors 
Individual game-by-game statistics for the 2009, 2010, and 2011 baseball seasons 
were publicly available from the HPU sports information department web site.  The sport 
performance risk factors derived from game statistics encompassed the following 
variables: playing position, average game appearances per season (GA) by playing 
position, average innings pitched per season per season (IP), average number of pitches 
per season (NP), average number of pitches per game appearances per season (NP/GA), 
average number of pitches per innings pitched per season (NP /IP), and average at-bats 
per season (AB).  Subjects were dichotomously labeled “pitcher” or “fielder” based on an 
athlete’s primary playing position.  Direct game play exposure was determined from GA, 
IP, NP, NP/ GA, NP/IP, and AB.  Sport Performance variables are listed in Table 9. 
 
Table 9. Independent Variables for CPM Development: Self-Report Measures and Sport 
Performance Risk Factors 
 
Domain Predictor Variable(s) Variable Type 
Self-Report Measures  
 KJOC-SES Score Continuous 
Sport Performance Risk Factors  
 playing position Nominal 
 game appearances- pitcher
a
 Continuous 
 game appearances- fielder
a
 Continuous 
 innings pitched
a
 Continuous 
 number of pitches
a
 Continuous 
 number of pitches per game appearance
a
 Continuous 
 number of pitches per inning
a
 Continuous 
 at-bats
a
 Continuous 
Note. 
a
average per season.   
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Functional Performance Measures 
FPMs were derived from the TEAM-S (Hegedus, 2011) (Appendix B).  The 
TEAM-S is a 15-item screening battery that also includes a qualitative dyskinesis 
screening test as a separate item for UE dominant athletes (baseball and volleyball).  The 
TEAM-S was scored as described by Hegedus (2011) with individual items being scored 
on 6-point rating (0, 1, 2, 3, 4, 5) based on specific scoring criteria.  For items that had 
recorded left and right measures, the lower score was utilized in determining the item’s 
rating scale score.  A brief summary of individual TEAM-S item scoring criteria is 
provided in Table 10 and described in the TEAM-S scoring sheet (see Appendix B).  A 
TEAM-S composite score was derived by summing the 15 items and the qualitative 
dyskinesis screening test for a maximum score of 80 points.  Table 10 provides a list of 
the individual TEAM-S items and their respective scoring metrics. 
The TEAM-S was administered by a group of clinicians consisting of two 
physical therapists, three athletic trainers, two certified strength and condition coaches, 
and three undergraduate exercise science students.  Experienced raters reviewed the 
TEAM-S scoring sheet and received verbal instructions on the procedure for 
administering the TEAM-S battery of FPMs from the research team’s principal 
investigator (E. J. Hegedus) prior to data collection.  Student raters underwent a similar 
orientation, but also were required to observe a group testing session prior to data 
collection.  Student raters were intentionally assigned TEAM-S items that required 
timekeeping and repetitive counting skills.  The intra- and inter-rater reliability for 
experienced and student raters was not determined.  
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Table 10. Functional Performance Measures: TEAM-S Item Scoring Criteria 
 
TEAM-S Item Predictor 
Variable(s) 
Rating 
Scale 
Scoring Criteria 
1 Beighton 
Hypermobility  
Brighton Score 0 to 5  Beighton index  
2 Full Squat Full Squat Score 0 to 5  Qualitative assessment 
3 Single Leg 
Squat
a
 
Single Leg Squat 
Score 
0 to 5  Qualitative assessment 
4 Downward Dog  Downward Dog 
Score 
0 to 5  Qualitative assessment 
5 Active Straight 
Leg Raise 
Active Straight Leg 
Raise Score 
0 to 5  Qualitative assessment 
6 Shoulder 
Mobility Test
a
 
Shoulder Mobility 
Test Score 
0 to 5  Qualitative assessment 
7 Y-Balance for 
Upper-
extremity
a
 
Y-Balance Score  0 to 5  Sum of greatest 3 reaches (cm) 
divided by 3 x 100; percentage of 
right versus left. 
8 CKCuest CKCuest Score 0 to 5  Number of repetitions in 15 
seconds 
9 Side Plank Hip 
Abduction
a
  
Side Plank Hip 
Abduction Score 
0 to 5  Number of repetitions in 30 
seconds 
10 Side Plank Hip 
Adduction 
a
  
Side Plank Hip 
Adduction Score 
0 to 5  Number of repetitions in 30 
seconds 
11 Nordic 
Hamstring Test 
Nordic Score 0 to 5  Knee flexion angle (degrees) 
12 Triple Hop for 
Distance
a
 
Triple Hop Score 0 to 5  Total distance (in) jumped on 
each leg; least distance /greatest 
distance x 100 
13 Vertical Leap Vertical Leap Score 0 to 5  Vertical jump height (in) 
14 In-line lunge for 
Distance 
a
 
In-line Lunge Score 0 to 5  Total lunge distance (in) each leg; 
least distance /greatest distance x 
100 
15 Lateral Lunge 
for Distance
a
 
Lateral Lung Score 0 to 5  Total lunge distance (in) each leg; 
least distance /greatest distance x 
100 
16 Qualitative 
Dyskinesis 
Screening Test
a
 
Scapula Dyskinesis 
Score 
0 to 5  Qualitative assessment 
Total  TEAM-S Total 
Score
b 
0-80  
Note. Each TEAM-S item is scored on a 6-point rating scale (0-1-2-3-4-5). The criteria 
for the rating scale are unique to each item and are specified in the TEAM-S scoring 
sheet, refer to Appendix B; 
a
Item measured bilaterally; 
b
Team-S Total Score is based on 
the sum of 16 items; in = inches; cm = centimeters.  
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TEAM-S items based on left and right side measures were coded based on 
dominant throwing arm.  For right handed dominant throwers, right side UE variables 
were coded as “throwing arm” and left side UE variables were coded as “non-throwing 
arm.”  Lower-extremity (LE) variables were coded as follows: for right handed dominant 
throwers, right side LE variables were coded as “balance foot” and left side LE variables 
were coded as “stride foot”.  TEAM-S variables for left handed dominant throwers were 
coded similarly, with opposing designations.  Coding based on arm dominance allowed 
for comparisons of throwing arm, non-throwing arm, stride foot, and balance foot in 
addition to a right versus left comparison.  The calculation of UE ratios were derived 
from the percentage of the throwing arm versus the non-throwing arm.  LE ratios were 
derived from the percentage of the stride foot versus the balance foot.  See Table 11 for a 
listing of UE and LE ratio variables. 
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Table 11. Independent Variables for CPM Development: Functional Performance 
Measure Risk Factors 
 
Domain Predictor Variable(s) Variable Type 
Functional Performance Measures 
 TEAM-S Total Score Continuous 
 Brighton Score Ordinal 
 Full Squat Score Ordinal 
 Single Leg Squat Score Ordinal 
 Single Leg Squat Stride Foot Ordinal 
 Single Leg Squat Balance Foot Ordinal 
 Downward Dog Score Ordinal 
 Active Straight Leg Raise Score Ordinal 
 Active Straight Leg Raise Stride Foot Ordinal 
 Active Straight Leg Raise Balance Foot Ordinal 
 Shoulder Mobility Test Score Ordinal 
 Shoulder Mobility Test Non-Throwing Arm Ordinal 
 Shoulder Mobility Test Throwing Arm Ordinal  
 Y-Balance Score Ordinal 
 Y-Balance Non-throwing Arm (cm) Continuous 
 Y-Balance Throwing Arm (cm) Continuous 
 Y-Balance Ratio
 b
 Continuous 
 CKCuest Score Ordinal 
 CKCuest Absolute
a
 Continuous 
 Side Plank Hip Abduction Score Ordinal 
 Side Plank Hip Abduction Stride Foot Absolute
 a
  Continuous 
 Side Plank Hip Abduction Balance Foot Absolute
 a
  Continuous 
 Side Plank Hip Abduction Ratio
 c
 Continuous 
 Side Plank Hip Adduction Score Ordinal 
 Side Plank Hip Adduction Stride Foot Absolute
 a
  Continuous 
 Side Plank Hip Adduction Balance Foot Absolute
 a
 Continuous 
 Side Plank Hip Adduction Ratio
 c
 Continuous 
 Nordic Score Ordinal 
 Triple Hop Score Ordinal 
 Tripe Hop Stride Foot (in) Continuous 
 Triple Hop Balance Foot (in) Continuous 
 Triple Hop Ratio
 c
 Continuous 
 Vertical Leap Score Ordinal 
 Vertical Leap Absolute (in) Continuous 
 In-line Lunge Score Ordinal 
 
 
59 
Table 11 (continued) 
 
Domain Predictor Variable(s) Variable Type 
Functional Performance Measures 
 In-line Lunge Stride Foot (in) Continuous 
 In-line Lunge Balance Foot (in) Continuous 
 In-line Lunge Ratio
 c
 Continuous 
 Lateral Lunge Score Ordinal 
 Lateral Lunge Stride Foot (in) Continuous 
 Lateral Lunge Balance Foot (in) Continuous 
 Lateral Lunge Ratio
 c
 Continuous 
 Scapula Dyskinesis Score Ordinal 
Note.  a Number of repetitions; 
b
 Upper extremity ratio is the percentage of throwing arm 
versus non-throwing arm; 
c
 Lower extremity ratio is the percentage of stride foot versus 
balance foot); in = inches; cm = centimeters. 
 
 
Approach for Specific Aim One 
Specific Aim One was to identify individual factors specific to self-reported 
outcome measures (as measured by KJOC score), sport performance risk factors (as 
measured by game statistics and coaching measures), and FPMs (as measured by scores 
from TEAM-S items) that differed between previously injured and uninjured cohorts.  
Factors that statistically differed by injury status were retained for additional analysis 
(Specific Aim Two) to develop a multifactorial CPM.  Through the construction of 2x2 
contingency tables we determined the diagnostic utility of individual factors (see Tables 9 
– 11) that significantly differed between injured and non-injured cohorts.  Individual 
factors were binary coded as positive (1) or negative (0) for injury status and 
wereexpressed through Bayesian statistics (Sn, Sp, LR+, LR-, and DOR). 
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Approach for Specific Aim Two 
Specific Aim Two was to determine whether the individual factors identified in 
Specific Aim One collectively would retrospectively predict injury status.  Individual 
factors were analyzed through forward stepwise logistic regression to determine the best 
combination of factors for predicting injury status.  The diagnostic utility of the 
multifactorial CPM was expressed through Bayesian statistics (Sn, Sp, LR+, LR-, and 
DOR). 
Variables 
Independent variables for this study included predictors from the self-reported 
outcome measures, sport performance risk factors, and FPMs.  Tables 10 and 11 provide 
a detailed list of the independent variables extracted from the self-report outcome 
measures, sport performance risk factors, and FPMs as previously described.  The 
dependent variable for this study was self-reported history of UE SRI and was 
categorized as non-injured (0) or injured (1). 
Statistical Analyses 
After subjects were dichotomously categorized based on UE SRI history to create 
two outcome groups (non-injured and injured), we determined which factors would be 
included in the CPM by group (non-injured or injured) comparison of each independent 
variable using univariate analysis (Specific Aim One).  Continuous independent variables 
were tested using an independent sample t test.  Nominal categorical independent 
variables were tested using the Chi-square test.  Ordinal scale independent variables were 
tested using the Mann-Whitney U test.  This approach for univariate analysis has been 
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outlined by Bruce & Wilkerson (2010) and was representative of reported statistical 
approaches for CPM development (Hicks et al., 2005; Raney et al., 2009; Teyhen, Flynn, 
Childs, & Abraham, 2007).  Independent variables with a p-value of ≤ 0.1 were retained 
as potential predictor variables for the CPM (Bruce & Wilkerson, 2010a; Hicks et al., 
2005; Raney et al., 2009; Teyhen et al., 2007; Wilkerson et al., 2012).  A liberal 
significance level was utilized for univariate analysis to ensure appropriate identification 
of potential predictor variables for the subsequent multivariate analysis.  The purpose of 
screening independent variables with a liberal significance level in the derivation phase 
of developing a CPM was to identify and retain potential predictive values that may 
individually have a weak relationship to the outcome variable but when combined with 
other predictive values in a multifactorial model may demonstrate a stronger statistical 
relationship to the outcome variable (Bruce & Wilkerson, 2010a). 
Secondarily for Specific Aim One, statistically significant continuous variables 
were further analyzed by constructing receiver operator characteristic (ROC) curves.  
ROC curves were used to establish a cutoff score with the greatest diagnostic utility and 
to define a positive risk factor.  Once a cutoff score was established for each predictor 
variable, each case was coded as positive (1) or negative (0) with respect to the cutoff 
score.  Contingency tables (2x2) were used to calculate Sn, Sp, LR+, LR-, and DOR with 
corresponding 95% confidence intervals (CI) based on the cutoff scores.  The cutoff 
scores for significant ordinal variables were based on the whole number score of the 
injured group.  Once a cutoff score was established for each predictor variable, each case 
was then coded as positive (1) or negative (0) with respect to the cutoff score.  
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Contingency tables (2x2) were used to calculate Sn, Sp, LR+, LR-, and DOR with 
corresponding 95% confidence intervals (CI) based on the cutoff scores.  Significant 
nominal variables were coded as positive (1) or negative (0) for each case.  2x2 
contingency tables were used to calculate Sn, Sp, LR+, LR-, and DOR with 
corresponding 95% CI for each respective variable.  The purpose of binary coding of 
statistically significant predictor variables as positive (1) and negative (0) was to establish 
the diagnostic utility of a given factor in relationship to the outcome variable (non-injured 
or injured).  This allowed for the calculation of the number of true positive, true negative, 
false positive, and false negative cases in a 2x2 contingency table and the subsequent 
calculation of Sn, Sp, LR+, LR-, and DOR for each predictor variable. 
After completing univariate analysis to determine which predictor variables 
significantly differed by injury status, a correlational matrix was used to determine 
whether similar predictor variables were highly correlated.  To minimize 
multicollinearity in logistic regression analysis, redundant correlated variables were 
eliminated based on the correlational matrix and DOR values prior to generating a final 
set of variables for multivariate analysis (Pallant, 2010).  Forward step-wise logistic 
regression analysis was used to determine which combination of these predictor variables 
provided the strongest predictive value of UE SRI history (Specific Aim Two).  A priori 
significance was set at p ≤ 0.05.  The multifactorial CPM of injury status was then 
analyzed per case and input into a 2x2 contingency table for the calculation of Sn, Sp, 
LR+, LR-, and DOR.  Data analysis was performed using IBM® SPSS® V20.0 (SPSS, 
Inc., Chicago, IL).  
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CHAPTER IV 
RESULTS 
 
 
The study developed and assessed a preliminary clinical prediction model (CPM) 
for upper-extremity (UE) sports related injury (SRI) in a retrospective cohort of collegiate 
baseball players.  The research design was a single-center retrospective cohort study.  
This chapter provides the descriptive data and statistical analyses for each hypothesis. 
Participants 
A total of thirty-seven Division I baseball players completed the PPE process, 
TEAM-S, and KJOC-SES.  The baseball players’ data from the TEAM-S and KJOC-SES 
were utilized to develop a CPM for UE SRI in collegiate baseball players.  One baseball 
athlete completed the PPE process and TEAM-S but did not complete the KJOC-SES.  
This subject’s data were excluded from the analysis, resulting in a final cohort of 36 
participants; (19.5 ±1.0 yrs, 183.3 ± 7.1 cm, 85.6 ± 10.6 kg) with 13.9 ± 3.1 years of 
playing experience. 
The cohort was comprised of 19 (53%) pitchers and 17 (47%) field position 
players.  The prevalence of dominant throwing arm SRI in this cohort (33%) was based 
on twelve self-reported injuries: five ulnar collateral ligament sprains, three shoulder 
impingements, two labium pathologies, and two rotator cuff tendinopathies (see Table 
12).  Based on this self-reported UE SRI history the cohort was divided dichotomously 
into non-injured (n = 24) and injured (n = 12) groups for univariate analyses.
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Table 12. Self-Reported UE SRI 
Pathology Cases (n = 12) 
Ulnar Collateral Ligament   5 
Shoulder Impingement 3 
Labrum  2 
Rotator Cuff Tendinopathy 2 
Note. UE SRI were for dominant throwing arm. 
 
 
Self-Reported Outcome Measures 
KJOC-SES scores differed significantly (p = .001) between non-injured and 
injured players (see Table 13). 
Sport Performance Risk Factors 
The non-injured group was comprised of eight (22%) pitchers and 16 (44%) field 
position players.  The injured group was comprised eleven (31%) pitchers and one (3%) 
field position player.  Chi square analysis of injury status by playing position revealed a 
significantly higher (10.92, df = 1, p = 0.001) injury rate for pitchers than expected. 
Sport performance risk factors for average game appearances per season (GA) for 
pitchers and fielders, average innings pitched per season (IP), average number of pitches 
per season (NP), average number of pitches per game appearances per season (NP/GA), 
average number of pitches per innings pitched per season (NP /IP), and average at-bats 
per season (AB) were not significantly different between the non-injured and injured 
groups.  Summary data for these variables can be found in Table 13. 
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Table 13. Descriptive Data for Self-Reported Measures and Sport Performance Risk 
Factors 
 
Domain Predictor Variable 
Non-Injured 
(n = 24) 
Injured 
( n = 12) 
p-value 
Self-Report Measures    
 KJOC-SES 89.6 ± 9.9 78.1 ± 7.6 .001 
     
Sport Performance Risk factors    
 Playing Position   .001† 
 Pitcher 8 11  
 Fielder 16 1  
 
GA - Pitcher 
6 ± 5.1 
(n = 3) 
13.3 ± 7.5 
(n = 8) 
.18 
 
GA - Fielders 
39.7 ± 11.3 
(n = 7) 
6 
(n = 1) 
na 
 
IP 
11.4 ± 10.5 
(n = 3) 
24.7 ± 18.8 
(n = 8) 
.287 
 
NP 
203.6 ± 
213.3 
(n = 3) 
445.9 ± 
372.7 
(n = 8) 
.325 
 
NP/GA 
27.7 ± 8.1 
(n = 3) 
35.4 ± 22.9 
(n = 8) 
.597 
 
NP/IP 
17.4 ± 3.8 
(n = 3) 
18.2 ± 2.5 
(n = 8) 
.693 
 
AB 
117.8 ± 73.2 
(n = 7) 
5.5 
(n = 1) 
na 
Note. mean ± standard deviation; GA = average game appearances per season; IP = 
average innings pitched per season; NP = average number of pitches per season; NP/GA 
= average number of pitches per game appearances per season; NP /IP = average number 
of pitches per innings pitched per season; AB = average at-bats per season. 
† Injury Status *Playing Position, Chi-square 10.92, df = 1, p = 0.001 
 
 
Functional Performance Measures 
Of the sixteen individual TEAM-S scored items, only single leg squat and the 
CKCUEST differed significantly between injured and non-injured groups.  Additional 
group comparison of predictor variables based on absolute scores—throwing arm 
dominance (throwing arm, non-throwing arm, stride foot, and balance foot), upper-
extremity ratios, and lower-extremity ratios were significantly different between injured 
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and non-injured for the following variables: single leg squat stride foot, single leg squat 
balance foot, shoulder mobility test throwing arm, shoulder mobility test non-throwing 
arm, and CKCUEST (absolute score).  The TEAM-S total score was not different 
between the injured and non-injured groups.  Table 14 provides a data summary of all 
TEAM-S predictor variables and total scores. 
Collectively, univariate analyses identified nine significant (p ≤ 0.10) predictor 
variables: KJOC-SES, playing position (pitcher), single leg squat stride foot, single leg 
squat balance foot, shoulder mobility test throwing arm, shoulder mobility test non-
throwing arm, CKCUEST  (TEAM-S score), and CKCUEST (absolute score). 
 To determine a discriminatory cutoff score for injured vs. non-injured, receiver 
operator characteristic (ROC) curves were constructed for continuous predictor variables.  
ROC analysis for KJOC-SES yielded a cutoff score of ≤ 86 and an area under the curve 
of 0.854.  ROC analysis for CKCUEST (absolute score) yielded a cutoff score of 24 and 
an area under the curve of 0.698 (see Appendix E for ROC curves).  Cutoff scores were 
then used to construct two-by-two (2x2) contingency tables and the subsequent 
calculation of diagnostic utility measures of sensitivity (Sn), specificity (Sp), positive 
likelihood ratio (LR+), negative likelihood ratios (LR-), and diagnostic odds ratio (DOR).  
Tables 15 and 16 provide the 2x2 contingency tables for these predictor variables. 
 Playing position was a significant predictor variable for injury status.  Because 
playing position was dichotomously coded into two categories, pitcher or fielder, a 2x2 
contingency table was constructed without the necessity of determining a discriminatory 
cutoff score.  Table 17 provides the 2x2 contingency table for playing position.  
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Table 14. Descriptive Data for TEAM-S Individual Items and Total Score 
 
Domain Predictor Variable 
Non-
Injured 
(n = 24) 
Injured 
(n = 12) 
p-value 
Functional Performance Measures 
1 Beighton 
Hypermobility  
4.7 ± 0.5 
(24) 
4.5 ± 0.6 
(12) 
.266 
2 Full Squat 4.4 ± 0.9 
(24) 
4.3 ± 0.9 
(12) 
1.00 
3a Single Leg Squat 4.2 ± 0.6 
(24) 
4.9 ± 0.2 
(12) 
.005 
3b Single Leg Squat 
Stride Foot 
4.5 ± 0.6 
(24) 
4.9 ± 0.2 
(12) 
.041 
3c Single Leg Squat 
Balance Foot 
4.4 ± 0.6 
(23) 
4.9 ± 0.2 
(12) 
.015 
4 Downward Dog  2.9 ± 1.2 
(24) 
3.0 ± 1.3 
(12) 
.498 
5a Active Straight Leg 
Raise 
3.5 ± 0.7 
(24) 
3.5 ± 0.5 
(12) 
.955 
5b Active Straight Leg 
Raise Stride Foot 
3.6 ± 0.7 
(24) 
3.75 ± 0.5 
(12) 
.683 
5c Active Straight Leg 
Raise Balance 
Foot 
3.5 ± 0.7 
(24) 
3.5 ± 0.5 
(12) 
.955 
6a Shoulder Mobility  
Test 
2.3 ± 0.4 
(24) 
2.7 ± 0.7 
(12) 
.136 
6b Shoulder Mobility  
Test Non- 
Throwing Arm 
2.83 ± 0.5 
(24) 
3.25 ± 0.4 
(12) 
.035 
6c Shoulder Mobility 
Test Throwing Arm 
2.3 ± 0.4 
(24) 
2.8 ± 0.8 
(12) 
.099 
7a Y-Balance for  
Upper-Extremity 
4.8±0.3 
(22) 
4.7±0.6 
(11) 
.668 
7b Y-Balance Non- 
throwing Arm 
(cm) 
279.9 ± 20.1 
(22) 
289.9 ± 21.3 
(12) 
.185 
7c Y-Balance  
Throwing Arm  
(cm) 
282.3 ± 20.3 
(24) 
288.6 ± 21.7 
(11) 
.413 
7d Y-Balance Ratio
b
 1.0 ± 0.0 
(22) 
1.0 ± 0.1 
(11) 
.949 
8a CKCUEST 3.9 ± 0.8 
(23) 
3.3 ± 0.5 
(11) 
.046 
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Table 14 (continued) 
 
8b CKCUEST  
Absolute
a 
26.0 ± 3.8 
(23) 
23.8 ± 2.4 
(11) 
.08 
9a Side Plank Hip  
Abduction  
5.0 ± 0.0 
(24) 
5.0 ± 0.0 
(12) 
1.00 
9b Side Plank Hip  
Abduction Stride  
Foot Absolute
a
 
54.9 ± 11.6 
(24) 
54.1 ± 8.8 
(12) 
.837 
9c Side Plank Hip  
Abduction 
Balance Foot  
Absolute
a
 
60.6 ± 11.1 
(24) 
55.75 ± 9.8 
(12) 
.203 
9d Side Plank Hip  
Abduction Ratio† 
0.91 ± 0.1 
(24) 
0.98 ± 0.1 
(12) 
.187 
10a Side Plank Hip  
Adduction  
5.0 ± 0.0 
(24) 
4.9 ± 0.2 
(12) 
.157 
10b Side Plank Hip  
Adduction Stride  
Foot Absolute
a
 
53.3 ± 8.7 
(24) 
48.9 ± 10.2 
(12) 
.184 
10c Side Plank Hip  
Adduction  
Balance Foot 
Absolute
a
 
54.5 ± 8.8 
(24) 
52.1 ± 8.8 
(12) 
.460 
10d Side Plank Hip  
Adduction Ratio
c
 
0.99 ± 0.1 
(24) 
0.94 ± 0.1 
(12) 
.463 
11 Nordic Hamstring  
Test 
2.5 ± 0.9 
(24) 
2.5 ± 0.9 
(12) 
.888 
12a Triple Hop for  
Distance 
4.5 ± 0.5 
(24) 
4.7 ± 0.4 
(11) 
.420 
12b Tripe Hop Stride  
Foot (in) 
230.2 ± 21.4 
(24) 
240.5 ± 30.6 
(12) 
.260 
12c Triple Hop Balance  
Foot (in) 
228.0 ± 19.3 
(24) 
240.4 ± 31.1 
(12) 
.152 
12d Triple Hop Ratio
c
 1.01 ± 0.6 
(24) 
0.99 ± 0.5 
(12) 
.434 
13a Vertical Leap 3.8 ± 0.9 
(24) 
3.4 ± 1.0 
(12) 
.283 
13b Vertical Leap  
Absolute (in) 
27.0 ± 3.8 
(24) 
25.4 ± 3.9 
(12) 
.268 
14a In-line lunge for  
Distance  
4.5 ± 0.8 
(24) 
4.6 ± 0.6 
(12) 
.591 
14b In-line Lunge Stride  
Foot (in) 
51.4 ± 5.3 
(24) 
50.4 ± 4.2 
(12) 
.559 
14c In-line Lunge  
Balance Foot (in) 
52.2 ± 5.0 
(24) 
50.8 ± 4.9 
(12) 
.416 
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Table 14 (continued) 
 
14d In-line Lunge Ratio
c
  0.98 ± 0.7 
(24) 
0.99 ± 0.0 
(12) 
.711 
15a Lateral Lung for  
Distance 
4.7 ± 0.4 
(24) 
4.5 ± 0.5 
(12) 
.460 
15b Lateral Lunge Stride  
Foot (in) 
56.3 ± 4.5 
(24) 
55.2 ± 4.1 
(12) 
.492 
15c Lateral Lunge  
Balance Foot (in) 
56.6 ± 5.0 
(24) 
54.4 ± 5.4 
(12) 
.243 
15d Lateral Lunge  
Ratio† 
.99 ± 0.4 
(24) 
1.01 ± 0.1 
(12) 
.175 
16a Qualitative  
Dyskinesis 
1.1 ± 0.3 
(24) 
1.1 ± 0.3 
(12) 
.737 
16b Scapula Dyskinesis  
Non-Throwing  
Arm 
2.3 ±0.7 
(24) 
2.5 ±0.6 
(12) 
.798 
16c Scapula Dyskinesis  
Throwing Arm 
2.2 ±0.8 
(24) 
2.2 ±0.9 
(12) 
.552 
 Total Score 61.9 ± 3.7 
(24) 
61.5 ± 4.0 
(12) 
.951 
Note. mean ± standard deviation ;Each TEAM-S item is scored on a 6-point rating scale 
(0-1-2-3-4-5). The criteria for the rating scale are unique to each item and are specifically 
outlined in the TEAM-S scoring sheet; refer to Appendix B. a Number of repetitions; 
b
 
Upper extremity ratio is the percentage of throwing arm versus non-throwing arm; 
c
 
Lower extremity ratio is the percentage of stride foot versus balance foot); in = inches; 
cm = centimeters.  
 
 
Table 15. 2x2 Contingency Table for KJOC-SES Score 
 
  UE SRI  
  Positive Negative Total 
KJOC-SES  86 
Positive 
 86 
11 
(True positive) 
4 
(False positive) 
15 
Negative 
> 86 
1 
(False negative) 
20 
(True negative) 
21 
 Total 12 24 36 
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Table 16. 2x2 Contingency Table for CKCUEST Absolute Score 
 
  UE SRI  
  Positive Negative Total 
CKCUEST Absolute 
Score ≤24 
Positive 
≤ 24 
8 
(True positive) 
7 
(False positive) 
15 
Negative 
> 24 
3 
(False negative) 
16 
(True negative) 
19 
 Total 11 23 34 
 
 
Table 17. 2x2 Contingency Table for Playing Position 
 
  UE SRI  
  Positive Negative Total 
Playing Position 
Pitcher 11 
(True positive) 
8 
(False positive) 
19 
Fielder 1 
(False negative) 
16 
(True negative) 
17 
 Total 12 24 36 
 
 
The cutoff scores for significant ordinal predictor variables (single leg squat stride 
foot, single leg squat balance foot, shoulder mobility test throwing arm, shoulder mobility test 
non-throwing arm, and CKCUEST [TEAM-S score]) were based on the whole number 
score of the injured group.  Once a cutoff score was established for each predictor 
variable, each case was coded as positive (1) or negative (0) and 2x2 contingency tables 
were used to calculate Sn, Sp, LR+, LR-, and DOR. 
Tables 18, 19, 20, 21, 22, and 23 provide the 2x2 contingency tables for Single 
Leg Squat, single leg squat stride foot, single leg squat balance foot, shoulder mobility test 
throwing arm, shoulder mobility test non-throwing arm, and CKCUEST  (TEAM-S score) 
respectively.  Table 24 provides a summary of diagnostic utility measures for all 
significant predictor variables.  
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Table 18. 2x2 Contingency Table Single Leg Squat - TEAM-S Score 
 
  UE SRI  
  Positive Negative Total 
Single Leg Squat 
TEAM-S Score 
Yes 
5 
11 
(True positive) 
10 
(False positive) 
21 
No 
≤ 4 
1 
(False negative) 
14 
(True negative) 
15 
 Total 12 24 36 
 
 
Table 19. 2x2 Contingency Table for Single Leg Squat Stride Foot  
 
  UE SRI  
  Positive Negative Total 
Single Leg Squat 
Stride Foot 
Yes 
5 
11 
(True positive) 
14 
(False positive) 
25 
No 
≤ 4 
1 
(False negative) 
10 
(True negative) 
11 
 Total 12 24 36 
 
 
Table 20. 2x2 Contingency Table for Single Leg Squat Balance Foot 
 
  UE SRI  
  Positive Negative Total 
Single Leg Squat 
Balance Foot 
Yes 
5 
11 
(True positive) 
12 
(False positive) 
23 
No 
≤ 4 
1 
(False negative) 
12 
(True negative) 
13 
 Total 12 15 36 
 
 
Table 21. 2x2 Contingency Table for Shoulder Mobility Test Throwing Arm 
 
  UE SRI  
  Positive Negative Total 
Shoulder Mobility 
Test Throwing 
Arm 
Yes 
≥ 3 
7 
(True positive) 
9 
(False positive) 
16 
No 
< 3 
5 
(False negative) 
15 
(True negative) 
20 
 Total 12 24 36 
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Table 22. 2x2 Contingency Table for Shoulder Mobility Test Non-Throwing Arm 
 
  UE SRI  
  Positive Negative Total 
Shoulder Mobility 
Test Non-
Throwing Arm 
Yes 
≥ 3 
12 
(True positive) 
18 
(False positive) 
30 
No 
< 3 
(0.5)
 a
 
(False negative) 
6 
(True negative) 
6 
 Total 12 24 36 
Note. 
a 
The actual false negative rate for the shoulder mobility test non-throwing arm is 
zero. The calculation of diagnostic utility measures requires a numerical value for each 
cell within the contingency table. To resolve this issue, 0.5 is substituted for zero. 
 
 
Table 23. 2x2 Contingency Table for CKCUEST - TEAM-S Score 
 
  UE SRI  
  Positive Negative Total 
CKCUEST - 
TEAM-S Score 
Yes 
≤ 3 
7 
(True positive) 
7 
(False positive) 
14 
No 
≥ 4 
4 
(False negative) 
16 
(True negative) 
20 
 Total 12 23 34 
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Table 24. Diagnostic Utility Values of Significant Predictor Variables 
 
 Predictor Variable Sensitivity
a
 Specificity LR+ LR- DOR 
Continuous       
 KJOC-SES  86 0.91 
(0.64-0.98) 
0.83 
(0.64-0.93) 
5.5 
(2.2-13.6) 
0.10 
(0.01-0.65) 
55.0 
(5.4-554.9) 
 CKCUEST (absolute) ≤ 24 0.72 
(0.43-0.84) 
0.69 
(.49-.84) 
2.3 
(1.1-4.8) 
0.39 
(0.14-1.06) 
6.0 
(1.2-30.0) 
Categorical       
 Playing Position (pitcher) 0.91 
(0.64-0.98) 
0.66 
(0.46-0.82) 
2.7 
(1.5-4.9) 
0.12 
(0.01-0.83) 
22.0  
(2.3-201.7) 
Ordinal   
     
 Single Leg Squat - 
TEAM-S Score 
0.91 
(0.64-.98) 
0.58 
(0.38-0.75) 
2.2 
(1.3-3.6) 
0.14 
(0.02-0.96) 
15.4 
(1.7-139.2) 
 Single Leg Squat 
Stride Foot 
0.91 
(0.64-0.98) 
0.41 
(0.24-0.61) 
1.5 
(1.0-2.2) 
0.2 
(0.02-1.3 
7.85 
(0.8-71.0) 
 Single leg Squat Balance Foot 0.91 
(0.64-0.98) 
0.5 
(0.31-0.68) 
1.8 
(1.1-2.8) 
0.16 
(0.02-1.1) 
11.0 
(1.2-99.0) 
 Shoulder Mobility Test 
Throwing Arm 
0.58 
(0.31-0.80) 
0.62 
(.42-0.78) 
1.5 
(0.7-3.1) 
0.66 
(0.31-1.3) 
2.33 
(0.5-9.5) 
 Shoulder Mobility Test  
Non-Throwing Arm 
0.96 
(0.70-0.99) 
0.25 
(0.12-0.44) 
1.2 
(0.99-1.6) 
0.16 
(0.01-2.6) 
8.0 
(0.4-156.8) 
 CKCUEST-TEAM S 0.63 
(0.35-0.84) 
0.69 
(0.49-0.84) 
2.0 
(0.9-4.4) 
0.52 
(0.17-1.14) 
4.0 
(0.8-18.2) 
Note. 
a 
Value (95% Confidence Interval); LR+ = positive likelihood ratio; LR- = negative likelihood ratio;  
DOR = diagnostic odds ratio 
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Clinical Prediction Model 
 
Specific Aim Two of this study was to determine whether the individual factors 
related to self-reported outcome measures, sport performance risk factors statistics, and 
FPMs identified in Specific Aim One would retrospectively predict injury status in a 
Clinical Prediction Model (CPM).  Within the set of identified risk factor variables, 
duplication existed among (a) single leg squat, single leg squat stride foot, and single leg 
squat balance foot, (b) shoulder mobility test throwing arm and shoulder mobility test 
non-throwing arm, and (c) CKCUEST (TEAM-S score) and CKCUEST (absolute score).  
Given the relatively low n of the study and the large number (n = 9) of predictor 
variables, a correlational analyses was performed to determine collinearity of 
similarpredictor variables (see Table 25).  Single leg squat was correlated with the single 
leg squat stride foot (p  0.0001; r = 0.846) and the single leg squat balance foot (p  
0.0001; r = 0.904).  Shoulder mobility test throwing arm and shoulder mobility test non-
throwing arm also were correlated (p = 0.009; r = 0.943).  CKCUEST (TEAM-S score) 
and CKCUEST (absolute score) had a significant (p  0.0001) and very strong positive  
correlation (r = 0.901).  Based on these correlational analyses and DOR values, we 
elected to only retain the single leg squat, shoulder mobility test throwing arm, and 
CKCUEST (absolute score) for multivariate analysis. Thus, KJOC-SES, playing position, 
single leg squat, shoulder mobility test throwing arm, and CKCUEST (absolute score) 
variables were used in a forward step-wise logistic regression to retrospectively predict 
injury status in the cohort of 36 collegiate baseball players. 
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Table 25. Correlational Matrix for Predictor Variables 
 
 Variable‡ 
SLS 
SLS 
SF 
SLS 
BL 
SHMT 
TA 
SHMT 
NTA 
CKCUEST 
TEAM-S 
CKCUEST 
(absolute) 
SLS 
Pearson r  1 
      
Sig. (2-
tailed)        
n 36 
      
SLS SF 
Pearson r   .846
**
 1 
     
Sig. (2-
tailed) 
.000 
      
n 36 36 
     
SLS BL 
Pearson r   .904
**
 .685
**
 1 
    
Sig. (2-
tailed) 
.000 .000 
     
n 36 36 36 
    
SHMT TA 
Pearson r   .367
*
 .284 .428
**
 1 
   
Sig. (2-
tailed) 
.028 .093 .009 
    
n 36 36 36 36 
   
SHMT 
NTA 
Pearson r   .039 -.031 .049 .431
**
 1 
  
Sig. (2-
tailed) 
.821 .857 .775 .009 
   
n 36 36 36 36 36 
  
CKCUEST 
TEAM-S 
Pearson r   -.202 -.076 -.249 -.172 .103 1 
 
Sig. (2-
tailed) 
.251 .671 .156 .330 .562 
  
n 34 34 34 34 34 34 
 
CKCUEST 
(absolute) 
Pearson r   -.177 -.151 -.187 -.213 .057 .901
**
 1 
Sig. (2-
tailed) 
.318 .395 .290 .227 .751 .000 
 
n 34 34 34 34 34 34 34 
Note. ‡SLS = Single Leg Squat; SLS SF = Single Leg Squat Stride Foot; SLS BF = 
Single Leg Squat Balance Foot; SHMT TA = Shoulder Mobility Test Throwing Arm; 
SHMT NTA = Shoulder Mobility Test Non-Throwing Arm; **Correlation is significant 
at the 0.01 level; * Correlation is significant at the 0.05 level.  
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The resultant model included two predictor variables; playing position and KJOC-SES.  
Table 26 provides the logistic regression prediction for UE SRI.  A test of the full model 
against a constant-only model was significant (Chi square = 22.4, p < 0.0001; df = 2). 
 
Table 26. Logistic Regression Prediction of UE SRI 
Variables in the Equation 
 
B S.E. Wald df Sig. Odds Ratio 
95% C.I. for 
Odds Ratio 
Lower Upper 
Step 1
a
 Playing 
Position 
3.129 1.143 7.502 1 .006 22.85 2.435 214.555 
Constant -2.773 1.031 7.235 1 .007 .06 
  
Step 2
b
 Playing 
Position 
5.002 2.127 5.532 1 .019 148.63 2.301 9599.488 
KJOC -.179 .076 5.593 1 .018 .83 .721 .970 
Constant 10.817 5.223 4.289 1 .038 49883.39 
  
Note. 
a
Variable(s) entered on step 1: Playing Position; 
b
Variable(s) entered on step 2: 
KJOC; Final model contained two-factors, Playing Position and KJOC-SES.  
 
 
 The full model explained between 48.1% (Cox and Snell R2) and 67.2% 
(Nagelkerke’s R
2
) of the variance in injury status, and correctly classified 85.3% of the 
cases (81.8% for injured and 87% for non-injured).  The strongest predictor for reported 
UE SRI was playing position with pitcher having an odds ratio of 148.  This indicates 
that pitchers were 148.6 times more likely to report an UE SRI.  An odds ratio of 0.84 for 
KJOC-SES (i.e., <1) indicated that for every point lower scored on the KJOC-SES, 
baseball players were 0.16 times more likely to report a UE SRI. 
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A 2x2 contingency table for the two-factor statistical model derived from logistic 
regression was constructed (see Table 27) with the diagnostic utility measures for the 
model presented in Table 28.  The KJOC-SES based on the cutoff score of 86 and 
playing position (pitcher) were applied to the original raw data (n = 36).  Cases which 
met both KJOC-SES (≤ 86) and playing position (pitcher) were coded as positive (1) 
while all other cases were coded as negative (0).  A 2x2 contingency table based on the 
application of these predictive factors was constructed (see Table 29).  The corresponding 
diagnostic utility values for the CPM are presented in Table 28. 
 
Table 27. 2x2 Contingency Table for Two-Factor Statistical Model 
 
  UE SRI  
  Positive Negative Total 
Two-Factor 
Statistical Model 
Yes 
 
9 
(True positive) 
2 
(False positive) 
11 
No 
 
3 
(False negative) 
20 
(True negative) 
23 
 Total 12 22 34 
Note. The data reflects a two-factor statistical model derived from forward step-wise 
logistic regression and was comprised of KJOC-SES and Player Position. For the logistic 
regression analysis, KJOC-SES data were retained in a continuous variable state, while 
Player Position was binary coded as pitcher (1) and fielder (0). 
 
 
Table 28. Diagnostic Utility Values of Two-Factor Models 
 
Model Sensitivity Specificity LR+ LR- DOR 
Statistical 
Model 
0.75 
(0.42.- 0.94) 
0.90 
(0.70-.98) 
8.25 
(2.1-32.1) 
0.27 
(0.1-0.74) 
30.0 
(4.2-211.8) 
CPM 
0.83 
(0.55 - 0.95) 
0.95 
(0.79 -0.99) 
22.0 
(2.88-138.5) 
0.17 
(0.04-0.61) 
115.0 
(9.32-1418.8) 
Note. Value with 95% Confidence Interval; LR+ = positive likelihood ratio; LR- = 
negative likelihood ratio; DOR = diagnostic odds ratio 
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Table 29. 2x2 Contingency Table for Two-Factor CPM  
 
  UE SRI  
  Positive Negative Total 
Two-Factor CPM 
Yes 
 
10 
(True positive) 
1 
(False positive) 
11 
No 
 
2 
(False negative) 
23 
(True negative) 
25 
 Total 12 24 36 
Note. The data reflect a two-factor CPM comprised of the predictor variables KJOC-SES 
(≤ 86) and Playing Position (pitcher). 
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CHAPTER V 
DISCUSSION 
 
Baseball is a popular international sport played on youth, high school, collegiate, 
and professional levels.  Over the past decade there has been a disproportional rise in 
serious upper-extremity (UE) sports related injury (SRI) necessitating surgery (Petty et 
al., 2004).  This trend has led to a call for further clarification of the relationship between 
risk factors and injury (McHugh et al., 2012).  Understanding the relationship between 
risk factors and UE SRI is complex because most athletes who sustain injury present with 
multiple risk factors (Petty et al., 2004).  Although a number of baseball-specific risk 
factors have been independently described (Fleisig et al., 2010; Hootman et al., 2007; 
Olsen et al., 2006; Wilk et al., 2010), a multifactorial model has not been developed to 
aid in the clinical diagnosis of UE SRI.  The collective inclusion of risk factors based on 
self-reported outcome measures (Domb et al., 2010; Neuman et al., 2011; Thigpen & 
Shanley, 2011), sport performance risk factors (Fleisig et al., 2010; Olsen et al., 2006), 
and functional performance measures (FPM) (G. Cook et al., 2006a, 2006b; G. Cook et 
al., 2010; Kiesel et al., 2007) may be important in establishing a clinical prediction model 
(CPM) specific to the baseball population.  Furthermore, the recent emphasis on the 
evidence-based practice paradigm in athletic training (BOC, 2010; NATA, 2010) 
demands consideration of research models that advance patient-oriented clinical practice 
(Snyder et al., 2008; Valovich McLeod et al., 2008).  A CPM that includes patient-
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oriented outcome measures may be advantageous in clarifying the relationship between 
risk factors and baseball specific UE SRI.  Thus the purpose of this study was to develop 
and assess a preliminary CPM for UE SRI in a retrospective cohort of collegiate baseball 
players.  The CPM was derived from injury risk factors specific to self-reported outcome 
scores, sport performance, and FPM.  The main finding of our study was that a two-factor 
CPM which included player position and a self-reported outcome measure score 
retrospectively predicted UE SRI in a cohort of collegiate baseball players. 
Specific Aim One 
Hypothesis one was accepted as KJOC-SES, playing position, single leg squat 
(Team-S score), squat leg squat stride foot, single leg squat balance foot, shoulder 
mobility test throwing arm, shoulder mobility test non-throwing arm, CKCUEST 
(TEAM-S score), and CKCUEST (absolute score) were each independently significant 
retrospective predictor variables of  UE SRI in a cohort of college baseball players. 
Self-Reported Outcome Measures 
The KJOC-SES previously has been employed as a population-appropriate self-
report outcome measure for baseball players (Alberta et al., 2010; Domb et al., 2010; 
Neri et al., 2010; Neuman et al., 2011).  Our reported KJOC-SES values for injured and 
non-injured athletes were consistent with previously reported scores.  Table 30 provides a 
details summary of KJOC-SES values for this study and previous investigations. 
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Table 30. Summary of Reported KJOC-SES Values  
 
Category /Injury Status KJOC-SES 
Cutoff 
Score 
Sn (%) Sp (%) 
Alberta et al (2010)      
 Playing without Arm Pain 97.5 (7.8)
a
    
 Playing with Pain 64.1 (20.0)
 a
    
 Not Playing with Pain 44.9 (16.2)
 a
    
 No Injury 93.3 (11.2)
 a
    
 Elbow Injury 80.0 (23.3)
 a
    
 Shoulder Injury 64.7 (24.7)
 a
    
Domb et al. (2010) < 81.3  100
 b
 90
 b
 
 Control -  95.4 (93.8-97)
c
    
 Playing without Arm Pain 90.4 (86.7-94.2)
c
    
 Playing with Pain 73.5 (63.6-83.3)
c
    
 Not Playing with Pain 47.5 (35.8-59.3)
c
    
Wei et al. (2010)    
 Medial elbow pain 60.3
f 
   
Neuman et al. (2011)    
 All Cases -Type II SLAP 73.6 (39-100)
d
    
 Pitcher 73 (39.5-95)
d
    
 Position Player 70.5 (39-92.5)
d
    
Neri et al. (2011)    
 Control 96.4 (8.3)
a
    
 Type II SLAP Lesion 76.9 (63.5-92.5)
e
    
Jones et al (2012)    
 Anterior Shoulder Instability 82 (18.2)
a 
(range 28-100) 
   
Krautler et al. (2012)    
  94.8 (92.9-96.7)
c 
   
Current Investigation ≤ 86 91 (65-99)
c 
83 (70-87)
c 
 Previously Non-injured 89.6 (9.9)
a 
   
 Previously Injured 78.1 (7.6)
a 
   
Note. Sn = sensitivity; Sp = specificity; 
a
 mean with standard deviation; 
b
 95% confidence 
intervals not reported;
 c
 mean with 95% confidence intervals; 
d
 mean with range; 
e
 mean 
with interquartile (25%-75%) range, 
f 
mean reported only.  Alberta et al. (2010), cross 
validation of KJOC-SES in 282 overhead athletes, 211 of which were baseball players; 
Domb et al. (2010), 55 professional baseball players who underwent UCL reconstruction; 
Wei et al. (2010), 9 Little League pitchers with recent history of medial elbow pain; 
Neuman et al. (2011), retrospective review of 30 arthroscopic repairs of symptomatic 
type II SLAP lesion; Neri et al. (2011), 23 elite overhead athletes more than 1 year post 
arthroscopic repair of type II SLAP lesion; Jones et al. (2012), 20 overhead athletes who 
underwent arthroscopic capsular plication for anterior shoulder instability; Krautler et al. 
(2012), 44 asymptomatic professional pitchers.  
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The KJOC-SES values with respect to UE SRI have been validated primarily 
through retrospective descriptive studies (Alberta et al., 2010; Domb et al., 2010; Hsu et 
al., 2009; Neri et al., 2010; Neuman et al., 2011).  In asymptomatic overhead athletes, 
KJOS-SES scores were reported to range from 94.4 to 96.4 (Alberta et al., 2010; Domb et 
al., 2010; Kraeutler et al., 2012; Neri et al., 2010).  Albert et al. (2010) reported mean 
KJOC-SES ranging from 64.7 (elbow) to 80.0 (shoulder) in those with a positive history 
of injury.  In overhand athletes who underwent arthroscopic repair of Type II SLAP 
lesions, KJOC-SES scores ranged from 76.9 (Neri et al., 2010) to 73.6 (Neuman et al., 
2011).  In overhand athletes who underwent arthroscopic capsular plication for 
microtraumatic anterior shoulder instability had average KJOC-SES scores of 82 (Hsu et 
al., 2009).  In professional baseball players who had undergone UCL reconstruction 
KJOC-SES scores ranged from 47.5 (not playing because of arm pain) to 90.4 (playing 
without arm pain) with a cutoff score of <81.3 (Domb et al., 2010).  In Little League 
pitchers with medial elbow pain the KJOC-SES score averaged 60.3 (Sweitzer et al., 
2012).  Our KJOC-SES values were 89.6 (non-injured) and 78.1 (injured) with a 
discriminatory threshold of <86 identifying athletes with a positive UE SRI history.  
Thus, the KJOC-SES scores from this study were consistent with previously reported 
values (Alberta et al., 2010; Domb et al., 2010; Neri et al., 2010). 
In the current study, KJOC-SES values had the strongest individual diagnostic 
utility (see Table 24) of all measures assessed.  A KJOC-SES threshold score of ≤ 86 
(positive test) yielded high Sn of 91% and Sp of 83%.  A Sn of 91% indicates a high 
probability of a positive test (KJOC-SES ≤ 86) in athletes with a history of UE SRI.  
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Conversely, a KJOC-SES score of >86 (negative test) with a Sn of 88% indicates a high 
probability of a negative score in athletes without a history of UE SRI.  Collectively, 
KJOC-SES, Sn, and Sp demonstrate a very low false negative and slightly higher false 
positive (see Table 15). 
Corresponding KJOC-SES likelihood ratios were LR+ = 5.5; LR- = 0.1.  An LR+ 
>5 is interpreted as a moderate, important shift in pre-test to post-test probability while a 
LR- ≤0.1 yields a large, conclusive shift (Glynn & Weisbach, 2011; Guyatt et al., 2008).  
The interpretation of likelihood ratios for the KJOC-SES reiterates that a positive test 
(KJOC-SES ≤ 86) produced moderate diagnostic utility as an individual predictor of UE 
SRI.  Based on our UE SRI prevalence of 33% (pre-test odds), a positive test (KJOC-SES 
≤86) shifts the post-test probability to approximately 75%.  A negative test (KJOC-
SES>86) shifts the pre-test probability of 33% to a post-test probability of < 3%.  These 
shifts in probability based on a KJOC-SES cutoff score of ≤ 86 indicate that both positive 
and negative test results provide greater clarity in the diagnostic screening of UE SRI.  
Figure 4 provides a representation of Fagan’s nomogram based on our pretest probability 
for UE SRI and the associated likelihood ratios for the KJOC-SES. 
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Figure 4. Fagan’s Nomogram for KJOC-SES ≤ 86. 
Fagan’s nomogram taken from Glasziou (2001); For a positive test (KJOC-SES ≤ 86) the 
solid line represents pre-test probability 33% shifting to a post-test probability of 75% 
based on a LR+ of 5.5; For a negative test (KJOC-SES > 86, the dashed line represents 
pre-test probability of UE SRI of 33% shifting to post-test probability of 3% based on a 
LR- of 0.1. 
 
 
KJOC-SES, Sn and Sp, have been reported previously as 100% and 90%, 
respectively with a cutoff score of < 81.3 (Domb et al., 2010).  The KJOC-SES 
diagnostic utility measures reported by Domb et al. (2010) were based on a cohort (n = 
55) of professional baseball players who underwent UCL reconstruction surgery.  Our 
subject pool was comprised of college level athletes who self-reported a variety of 
shoulder and elbow SRI, five of which were UCL.  Alberta et al. (2010) reported 
different KJOC-SES scores among athletes with a history of elbow (80.0 ± 23.3) and 
shoulder (64.7 ± 24.7) injuries.  Because KJOC-SES values may differ based on joint 
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specificity, it is difficult to provide a direct comparison of our KJOC-SES diagnostic 
utility values with previously reported values.  Indirectly, our data appear consistent with 
Domb et al. (2010). 
Collectively, the diagnostic utility of the KJOC-SES ≤ 86 cutoff was clinically 
useful in delineating between injured and non-injured athletes based on retrospective 
analysis of UE SRI.  The combination of a very low false negative rate, high Sn, and low 
LR- suggests that the KJOC-SES, as a stand-alone clinical measurement, may be an 
excellent diagnostic screening tool in predicting UE SRI. 
Sport Performance Risk Factors 
Playing position was the only significant sport performance risk factor in 
distinguishing injured and non-injured groups, as pitchers had higher self-reported UE 
SRI rates compared to fielders (see Table 13).  This finding was consistent with existing 
evidence that UE SRI rates are higher among pitchers than field position players 
(Chambless et al., 2000; Fleisig et al., 2010; Kerut et al., 2008; Olsen et al., 2006). 
Playing position yielded low to moderate diagnostic utility as an individual 
predictor variable for UE SRI.  Playing position, coded positive test (pitcher) and 
negative test (fielder) had a high Sn of 91% but a moderate Sp of 66%.  Furthermore, it is 
important to recognize that playing position as a diagnostic screening measure was 
associated with a low false negative rate (2.7%) but a high false positive rate (22.2%).  
This suggests that a positive result (pitcher) over-identified the presence of UE SRI in 
non-injured athletes.  Subsequently, in the context of a high Sn and moderate Sp, a 
negative test (fielder) was more valuable at ruling out the probability of an UE SRI. 
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The likelihood ratios for playing position were LR+ = 2.75; LR- = 0.12.  An LR+ 
between 2 and 5 is interpreted as having a small but sometimes important shift in pre-test 
to post-test probability while a LR- between 0.1 and 0.2 yields a moderate, important 
shift (Glynn & Weisbach, 2011; Guyatt et al., 2008).  The interpretation of likelihood 
ratios by playing position demonstrates that a positive test (pitcher) produced low 
diagnostic utility as an individual predictor variable for UE SRI.  Based on our UE SRI 
prevalence of 33.3% (pre-test odds), a positive test shifts the post-test probability to 
47.8%.  Conversely, a negative test (fielder) shifted the pre-test probability from 33% to a 
post-test probability of 3.8%.  These shifts in probability based on playing position 
indicate that a negative test (fielder) provided greater diagnostic clarity versus a positive 
test (pitcher).  Figure 5 provides a representation of Fagan’s nomogram based on our 
pretest probability for UE SRI and the associated likelihood ratios for playing position. 
Collectively, pitchers had a higher injury rate than fielders.  However, the 
diagnostic utility of playing position provides low predictive value in relationship to UE 
SRI history.  This conclusion is based on two important factors.  First, a high false 
positive rate overestimates the presence of UE SRI.  Second, due to the high Sn and 
moderate Sp, a negative test (fielder) provides a stronger prediction of not having an UE 
SRI versus having a history of UE SRI.  Generally, diagnostic tests with high Sn are 
useful in identifying people without a target condition because of a very low false 
negative rate (Jewell, 2011). 
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Figure 5. Fagan’s Nomogram for Playing Position. 
Fagan’s Nomogram taken from Glasziou (2001);For a positive test (pitcher), the solid 
line represents a pre-test probability of 33% shifting to post-test probability of 
approximately 47.82% based on a LR+ of 2.75; For a negative test (fielder), the dashed 
line represents a pre-test probability of 33.3% shifting to a post-test probability of 3.8% 
based on a LR- of 0.12. 
 
 
The diagnostic utility of playing position is an illustrated case of the mnemonic 
“SnNout”: high Sensitivity, a Negative test rules out the diagnosis (Portney & Watkins, 
2009; Sackett et al., 1997).  The interpretation of Sn often seems counterintuitive in 
clinical practice.  Diagnostic measures with high Sn are useful in identifying people 
without a target condition because of their very low false negative rate.  Logically it may 
be assumed that a positive test result would translate as ruling in the presence of a target 
condition.  However, Sn does not account for false positive results.  Sn must be viewed in 
the context of Sp which does account for false positive test results.  Thus, when 
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adiagnostic test with a high Sn yields a negative test result, there is greater certainty in 
ruling out the target condition.  Despite pitchers having a higher injury rate than fielders, 
playing position as a diagnostic utility measure provides greater clinical interpretive 
value when negative (fielder coded as negative). 
The remaining sport performance risk factors of average game appearances per 
season (GA) for pitchers and fielders, average innings pitched per season per season (IP), 
average number of pitches per season (NP), average number of pitches per game 
appearances per season (NP/GA), average number of pitches per innings pitched per 
season (NP/IP), and average at-bats per season (AB) did not differ between the non-
injured and injured groups.  Theses finding are contrary to the reported link between 
select sport performance variables and UE SRI.  Specifically, throwing volume as 
measured through IP, NP, GA has been reported as a primary predisposing risk factor for 
UE SRI (Bradbury & Forman, 2012; Fleisig et al., 2010; Kohlmeyer, 2005; Olsen et al., 
2006).  Throwing volume is a distinct sport-related extrinsic risk factor that contributes to 
acute and overuse UE SRI (Fleisig et al., 2010; Lockard, 2006; Olsen et al., 2006).  
Subsequently, injury prevention strategies universally center on restricting IP, NP, and 
GA (Andrews & Fleisig, 1998; Fleisig et al., 2010; Fleisig & Andrews, 2012; Fleisig, 
Weber, Hassell, & Andrews, 2009; Olsen et al., 2006; Sciascia & Kibler, 2006).  Thus we 
included measures of throwing volume as sport performance risk factors to parallel the 
recent work of Olson et al. (2006) and Fleisig et al. (2010).  However, the current 
investigation did not support the relationship between UE SRI and throwing volume 
based on the sport performance measures of GA, IP, NP, NP/GA, NP/IP, or AB. 
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The inability of using sport performance measures of GA, IP, NP, NP/GA, NP/IP, 
or AB to predict UE SRI in our study may have been due to a number of factors.  First, 
our sample size may have been too small to provide the statistical power necessary to 
determine whether a difference existed between injured versus non-injured athletes.  
Second, the retrospective availability of individual game-by-game statistics was not 
equitable for all subjects across groups.  Individual game-by-game statistics were only 
available for 11 of the 19 (58%) pitchers and eight of 17 (47%) fielders.  This was 
attributed to redshirt or first year players who had not yet participated in games to 
generate game-by-game statistics.  Third, the use of game play statistical data to establish 
injury risk has only been demonstrated in a retrospective case with a control group design 
(Olsen et al., 2006) and a 10-year prospective cohort design using adolescent baseball 
players  (Fleisig et al., 2010).  Ultimately, the relationship between game play statistics 
and injury risk remains to be established for collegiate and professional baseball 
populations. 
Functional Performance Measures 
FPMs were obtained through the Targeted Enhanced Athletic Movement Screen 
(TEAM-S) global battery of physical performance measures.  The TEAM-S composite 
score did not differ between injured and non-injured groups.  This contradicts findings 
that an FPM battery (e.g., FMS™) could predict prospectively serious injury in 
professional football players (Kiesel et al., 2007).  However, more recently a growing 
body of evidence has called into question the validity of FPM batteries to predict injury 
in active military service members (Teyhen et al., 2012) and collegiate athletes (Winke, 
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Dalton, Mendell, & Nicchi, 2012).  It is believed that individual functional performance 
test scores derived from an FPM battery may be more predictive of specific injury types 
than a composite FPM score (Winke et al., 2012).  The absence of a significant TEAM-S 
composite score supports an emerging body of evidence that questions the validity of 
composite FPM scores in predicting those at risk of injury. 
From the individual measures that comprise the TEAM-S battery, a compilation 
of 45 individual predictor variables (see Table 14), only seven differed significantly 
between non-injured players and those with UE SRI: (a) single leg squat (TEAM-S), (b) 
single leg squat stride foot, (c) single leg squat balance foot, (d) shoulder mobility test- 
throwing arm, (e) shoulder mobility test- non-throwing arm, (f) CKCUEST (TEAM-S), 
and (g) CKCUEST (absolute score). 
Single Leg Squat 
The measures of single leg squat (TEAM-S), single leg squat stride foot, and 
single leg squat balance foot were considered qualitative measures of dynamic 
lumbopelvic control during a unilateral squat (see Appendix B).  The injured group 
scored higher in all three measures versus the non-injured group.  This finding contradicts 
the common assumption that injured athletes typically present with balance deficits 
compared to non-injured athletes (Hrysomallis, 2011).  Previous investigations have 
demonstrated a relationship between lower balance scores with respect to pitching 
performance (Chaudhari, McKenzie, Borchers, & Best, 2011; Hrysomallis, 2011; Marsh, 
Richard, Williams, & Lynch, 2004).  However, a relationship between lower extremity 
balance and UE injury rates has not been found (Chaudhari et al., 2011; Donatelli et al., 
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1999).  Because of this evidence, it is unknown why our data demonstrated higher single 
leg squat scores in the injured group. 
Single leg squat (TEAM-S), single leg squat stride foot, and single leg squat 
balance foot collectively demonstrated poor diagnostic utility (see Table 24).  All three 
measures yielded the same Sn of 91% (95% CI 64 - 98) with Sp values ranging from 41% 
(95% CI 24 – 61) to 58% (95% CI 38 - 75).  Although these Sn and Sp values are 
representative of established orthopedic special tests (C.E. Cook & Hegedus, 2013), all 
three measures present with high false positive rates ranging between 27.7 to 36% (see 
Tables 18, 19, and 20). 
The likelihood ratios ranges for the three single leg squat measures are LR+ = 1.5 
to 2.2 and LR- = 0.1.4 to 0.2; they provide very small diagnostic utility and are clinically 
irrelevant.  The single leg squat (Team-S) yielded higher quality likelihood ratios 
compared to single leg squat stride foot and single leg squat balance foot with an LR+ = 
2.2 and an LR- = 0.14.  Based on our UE SRI prevalence of 33.3% (pre-test odds), a 
positive test (score of 5) shifts the post-test probability to 42.8%, while a negative test 
(score ≤4) shifts the post-test probability to 4.4%.  These shifts in probability are of little 
help in making clinical decisions about injury status. 
Collectively, single leg squat (TEAM-S), single leg squat stride foot, and single 
leg squat balance foot are confounding positive findings with respect to common clinical 
thinking.  The diagnostic utility of the measures are characterized by high false positive 
rates, moderate Sp, and low LRs.  As stand-alone diagnostic screening measures, single 
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leg squat measures demonstrate significant values in delineating between injured and 
non-injured, but in a clinical context do not provide substantial diagnostic utility. 
Shoulder Mobility Test 
Specific adaptations in passive and active range of motion (ROM) patterns have 
been reported for overhead throwing athletes.  Passive external rotation (ER) and internal 
rotation (IR) at 90° abduction in the throwing shoulder have been measured between 128 
and 142°, and between 55 and 68° respectively, compared to 119 to 135° and 68 to 78° in 
the non-throwing shoulder (Borsa et al., 2006; Borsa et al., 2005; Crockett et al., 2002; 
Lintner, Mayol, Uzodinma, Jones, & Labossiere, 2007).  This loss of IR has been termed 
glenohumeral internal rotation deficit (GIRD) and is hypothesized to result in greater 
forces being absorbed by the shoulder and/or elbow complex.  Although GIRD has been 
identified in those with UE SRI (Bach & Goldberg, 2006; Laudner, Sipes, & Wilson, 
2008; Lintner et al., 2007; Tokish, Curtin, Kim, Hawkins, & Torry, 2008), the current 
study did not include direct glenohumeral joint ROM measures.  Instead, the shoulder 
mobility test provided a dynamic assessment of UE ROM (see Appendix B), which 
revealed no significant difference in shoulder mobility test scores between the throwing 
and non-throwing arm.  This finding contradicts the reported adaptive ROM patterns 
specific to throwing athletes that result in ROM asymmetry between dominant and non-
dominant throwing arms.  Unexpectedly, we found lower shoulder mobility test scores in 
the throwing arm than in the non-throwing arm irrespective of UE SRI status.  Again, this 
finding contradicts evidence indicating a loss of glenohumeral ROM, particularly GIRD, 
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is related to an increased risk of UE SRI.  Additionally, our finding seems to indicate that 
the shoulder mobility test may not be a valid ROM measure for baseball players. 
Typically the ROM values of the dominant arm are used as a risk factor for UE 
SRI.  However, diagnostic utility measures of the shoulder mobility test scores (≥ 3) were 
stronger for the non-throwing arm (albeit low quality) than the throwing arm (see Table 
24).  A positive shoulder mobility test non-throwing arm score (≥ 3) yielded zero false 
negative test results but a 50% false positive rate (see table 22).  The diagnostic utility 
measures for shoulder mobility test non-throwing arm (≥ 3) yielded a very high Sn 
(96%), very low Sp (25%) and very small, clinically irrelevant likelihood ratios with 
overlapping 95% confidence intervals (see Table 24).  A high Sn and low Sp may 
initially appear to be clinically valuable; however, overlapping likelihood ratios render 
the shoulder mobility test non-throwing arm (≥ 3) clinically useless as an individual 
screening tool for UE SRI. 
Current data collectively indicate that ROM as an injury risk factor in baseball 
players should not be assessed dynamically as is the shoulder mobility test.  Our shoulder 
mobility test throwing arm and shoulder mobility test non-throwing arm scores resulted 
in an atypical statistical and clinical relationship between injured and non-injured 
athletes.  The diagnostic utility of both shoulder mobility tests are of poor quality and are 
difficult to interpret in screening for UE SRI.  Although reported to be reliable (Frohm et 
al., 2011; Teyhen et al., 2012), the measure needs to be validated with respect to 
traditional shoulder ROM measures in overhead throwing populations to determine its 
value as a screening measure.  
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CKCUEST 
The Closed Kinetic Chain Upper Extremity Stability Test (CKCUEST ) was 
developed as a functional UE test to quantify patient progress in rehabilitation settings 
(Roush, Kitamura, & Waits, 2007).  Our reported CKCUEST (absolute score) values 
ranged from 23.8±2.4 (injured) to 26.0±3.8 (non-injured).  The CKCUEST (absolute 
score) values in the non-injured group were consistent with reference values for the 
CKCUEST scores ranging from 27.8 ±1.8 in college-aged males (Ellenbecker, Manske, 
& Davies, 2000) to 30.41±3.4 in healthy, non-injured collegiate baseball players (Roush 
et al., 2007). Normative values for CKCUEST in injured athletes had not been reported 
previously.  Our ROC analysis for CKCUEST (absolute scores) yielded a cutoff score of 
≤ 24 as the discriminatory threshold associated with UE SRI. 
The CKCUEST (TEAM-S) and CKCUEST (absolute score) demonstrated similar 
outcomes with the injured group scoring lower than the non-injured group.  Because the 
scoring metric for CKCUEST (TEAM-S) has a direct relationship with the number of 
touches in 15 seconds (CKCUEST absolute score) (see Appendix B), similar 2x2 
contingency tables (see Tables 16 and 23) and measures of diagnostic utility (see Table 
24) were found when comparing the measures.  Because the CKCUEST (≤ 24) is a direct 
reflection of raw data and demonstrated a higher diagnostic odds ratio (DOR) than 
CKCUEST (TEAM-S), the diagnostic utility of this FPM is best represented by the 
CKCUEST (≤ 24) data. 
A CKCUEST threshold cutoff score of ≤ 24 (positive test) yielded modest Sn of 
72% and Sp of 69%.  A Sn of 72% indicates a higher probability of a positive test 
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(CKCUEST ≤ 24) in athletes with a history of UE SRI and was subject to an 8.8% false 
negative rate.  Conversely, a CKCUEST score of > 24 (negative test) yielded a Sn of 
69%, indicating a higher probability of a negative score in athletes without a history of 
UE SRI, but is limited by high false positive rate (20.5%). 
The corresponding CKCUEST(< 24) likelihood ratios of LR+ = 2.3 and LR- = 
0.39 indicate that a positive test (score ≤ 24) produced modest diagnostic utility as an 
individual predictor variable for UE SRI.  Based on our UE SRI prevalence of 33% (pre-
test odds), a positive test (CKCUEST ≤ 24) shifted the post-test probability to 
approximately 43.3% while a negative test (CKCUEST > 24) shifted the pre-test 
probability from 33% to a post-test probability of 11.5%.  These shifts in probability 
based on a CKCUEST cutoff score of ≤ 24 indicate that a positive or negative test result 
provides little diagnostic clarity in the screening of UE SRI. 
Despite significant outcomes, the global diagnostic utility of the CKCUEST ≤ 24 
is not clinically useful in delineating between injured and non-injured athletes based on 
retrospective analysis of UE SRI.  The combination of a very high false positive rate, 
moderate Sn and Sp, and low LRs indicates that the CKCUEST as a stand-alone clinical 
measurement should not be used as a stand-alone diagnostic screening tool in predicting 
UE SRI. 
Specific Aim Two 
Hypothesis two was accepted as a two-factor CPM, comprised of KJOC-SES and 
playing position, retrospectively predicted UE SRI in a cohort of college baseball players 
with a greater degree of diagnostic utility than did the individual factors of KJOC-SES, 
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playing position, single leg (Team-S score), squat leg squat-stride foot, single leg squat-
balance foot, shoulder mobility test-throwing arm, shoulder mobility test-non-throwing 
arm, CKCUEST (TEAM-S Score), and CKCUEST (absolute score). 
Clinical Prediction Model 
The forward step-wise logistic regression analysis produced a two-factor 
statistical model comprised of KJOC-SES and playing position.  This model was based 
on n = 34 because CKCUEST data were missing for two subjects.  It should be noted that 
for the logistic regression analysis, continuous predictor variables (KJOC-SES and 
CKCUEST) were retained in their natural state rather than dichotomized based on 
receiver operator characteristic (ROC) curve cutoff values to preserve the integrity of the 
statistical approach.  The resultant statistical model yielded a strong set of diagnostic 
utility measures:  Sn of 75% (95% CI: 42 to 94); Sp of 90% (95% CI: 70 to 98); LR+ of 
8.25 (95% CI: 2.11 to 32.18); and LR- of 0.28 (95% CI: 0.1 to 0.74). 
The two-factor statistical model was applied to the original data set using the 
ROC curve cutoff value for KJOC-SES and playing position.  This provided the 
opportunity to maximize the number of available subjects and to test the statistical model 
clinically.  Because the KJOC-SES is scored on a continuous scale (0 to 100), it is 
difficult for a clinician to translate a score into a positive or negative finding without a 
normative reference score.  A KJOC-SES cutoff score ≤ 86 allows a clinician to 
interpreter the instrument’s results as positive or negative for diagnostic purposes.  
Therefore, applying the two-factor model based on a KJOC-SES ≤ 86 and playing 
position (pitcher) allowed the logistical regression statistical model to be translated into a 
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simplified set of clinical diagnostic parameters.  In essence this allows a statistical model 
to become an accessible clinical model (CPM) that can be applied directly in a patient 
context. 
The two-factor CPM applied to the original 36 subjects based on KJOC-SES ≤ 86 
and playing position (pitcher) yielded diagnostic utility measures as follows:  Sn of 83% 
(95% CI: 0.55 to 95); Sp of 95% (95% CI: 79 to 99); LR+ of 22.0 (95% CI: 2.88 to 
138.5); and LR- of 0.17 (95% CI: 0.04 to 0.61).  By comparison, the CPM demonstrated 
improved diagnostic utility for Sn, Sp, LRs, and DOR compared to the primary statistical 
model (see Table 28).  A Sn of 83% is indicative of a high probability of a positive test in 
athletes with a history of UE SRI, while an Sp of 95% indicates a high probability of a 
negative score in athletes without a history of UE SRI.  Collectively the two-factor CPM 
demonstrated both low false negative (2.7%) and false positive (5.5%) rates (see Table 
28).  The CPM’s likelihood ratios were 22.0 (LR+) and 0.17 (LR-) and affirm that 
positive and negative test results are equally important in predicting injury status.  Based 
on our UE SRI prevalence of 33% pre-test odds, a positive test shifts the post-test 
probability to approximately 88%.  A negative test shifts the pre-test probability from 
33% to a post-test probability of < 5.3%.  These shifts in pre-test to post-test probability 
are large and conclusive for diagnostic use.  Figure 6 provides a representation of Fagan’s 
nomogram based on our pretest probability for UE SRI and the associated likelihood 
ratios for the two-factor CPM. 
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Figure 6. Fagan’s Nomogram for Two-Factor CPM. 
Fagan’s nomogram taken from Glasziou (2001); For a positive screen, solid line 
represents pre-test probability 33% shifting to post-test probability of 88% based on a 
LR+ of 22.0; For a negative screen, the dashed line represents pre-test probability of UE 
SRI of 33% shifting to post-test probability of 5.3% based on a LR- of 0.17. 
 
 
To the best of our knowledge, this investigation provides the first CPM to predict 
UE SRI in college baseball players.  Ideally, our results should be viewed in direct 
comparison to other multifactorial baseball injury prediction models.  In the absence of 
other baseball specific CPMs, it is important to contextualize our model with respect to 
other SRI diagnostics (Bruce & Wilkerson, 2010b; Wilkerson, 2010) and traditional UE 
diagnostic models (Altman et al., 1990; Litaker, Pioro, El Bilbeisi, & Brems, 2000; Park, 
Yokota, Gill, El Rassi, & McFarland, 2005; Wainner et al., 2005). 
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Our study was initially modeled from the preliminary works of Bruce 
&Wilkerson (2010) and Wilkerson (2010) who developed CPMs specifically for athletic 
training.  Their CPMs were developed by combining select FPM and self-report outcome  
measures in single center cohorts for retrospectively predicting UE overuse injury in 
collegiate softball players (Bruce & Wilkerson, 2010b) and prospectively predicting core 
and lower extremity strains and sprains in collegiate football players (Wilkerson, 2010).  
Although we included FPMs as potential predictor variables, our final two-factor CPM 
did not include modifiable functional parameters such as the side bridge hold (Bruce & 
Wilkerson, 2010b), trunk flexion hold (Bruce & Wilkerson, 2010b; Wilkerson, 2010), 
and wall-sit hold (Wilkerson, Bullard, & Bartal, 2010).  Our study and Wilkerson (2010) 
both included regionally specific self-report functional outcome measures, the KJOC-
SES, and Oswestry Disability Index respectively.  With respect to diagnostic utility, our 
model yielded stronger measures for Sn, Sp, and LR+ and comparable LR- to Bruce & 
Wilkerson (2010) and Wilkerson (2010) (see Table 31).  
Traditionally, UE SRIs are diagnosed through a clinical examination sequence 
that includes patient history and orthopedic special tests.  Clusters of special tests have 
been combined to improve the accuracy of the clinical examination finding.  Several 
CPMs comprised of special test clusters have been developed to diagnose pathologies 
(Altman et al., 1990; Litaker et al., 2000; Park et al., 2005; Wainner et al., 2005).  With 
respect to the diagnostic utility of CPM special test clusters, our two-factor CPM 
demonstrated comparable of Sn, Sp, LR+, and LR- measures (see Table 31). 
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Table 31. Diagnostic Utility of CPMs 
 
Study Sensitivity Specificity LR+ LR- 
Evidence 
Level* 
SRI Prediction Models 
Bruce et al. (2010)    
 
0.42 
(0.19, 0.68) 
0.96 
(0.79, 0.99) 
9.58 
(1.3, 73.0) 
0.61 
(0.4, 1.0) 
IV 
Wilkerson et al. (2012)    
 
.62 
(0.46 - 75) 
.91 
(0.79 - 0.96) 
6.8
a
 0.09
a
 IV 
Current Investigation    
 
0.83 
(0.55  0.95) 
0.95 
(0.79 - 0.99) 
22.0 
(2.88 - 138.5) 
0.17 
(0.04 - 0.61) 
IV 
Diagnostic Special Test Clusters: UE Diagnostic Models 
Altman et al. (1990)    
 88%
b
 93%
b
 12.5
a 
0.07
a 
III 
Litaker et al. (2000)    
 49%
b
 95%
b
 9.8
b
 0.05
b
 III 
Wainner et al. (2005)    
 
0.18 
(.03 – .31)
 
0.99 
(0.97 – 1.0)
 
18.3 
(1.0 – 328.3)
 
0.18 
(.03 – 0.31)
 IV 
Park et al. (2005)  
 
 
† NR NR 10.56
b
 0.17
b 
IV 
‡ NR NR 15.57
b
 0.16
b 
IV 
Note. Value (95% Confidence Interval); LR+ = positive likelihood ratio; LR- = negative 
likelihood ratio; * CPM evidence level adapted from Glynn & Weishbach (2011); 
a
 
Likelihood ratios not reported, calculated from Sn and Sp; 
b 
95% confidence intervals not 
reported; Bruce et al. (2010) two-factor model for UE overuse injury in intercollegiate 
softball players (n = 35); Wilkerson et al. (2012) ≥3 factor model for core and LE strains 
and sprains in collegiate football players (n = 83); Altman et al. (1990) five-factor model 
for the diagnostic classification of osteoarthritis of the hand (n = 194); Litaker et al. 
(2000) three factor model for diagnosing rotator cuff tears (n = 448); Wainner et al. 
(2005) ≥ 4 factor model for diagnosing carpal tunnel syndrome (n = 82); Park et al. 
(2005) (n =1127) † three-factor model for diagnosing impingement syndrome, ‡ three-
factor model for diagnosing full thickness rotator cuff tears.  
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This indicates that our CPM’s diagnostic utility characteristics fall within a range 
acceptable for clinical practice.  Collectively, the diagnostic utility of our CPM was 
clinically useful in delineating between injured and non-injured athletes based on 
retrospective analysis of UE SRI.  The model correctly classified 85.5% of the cases 
(81.8% for the injured and 87% for the non-injured).  The combination of these 
diagnostic utility measures indicates that the two-factor CPM may be an excellent 
diagnostic screening tool for both ruling in and ruling out UE SRI in collegiate baseball 
players. 
Clinical Application 
The results from this study may provide a number of benefits in advancing 
evidence-based clinical practice.  First and foremost, we provided a review of diagnostic 
utility and their interpretive context for practicing clinicians.  The concepts of Sn, Sp, 
LR+, and LR- are important for clinicians to understand with respect to diagnostic special 
tests and screening.  Furthermore, clinicians need working knowledge of how 
diagnosticutility measures relate to pre-test and post-test probability in forming a clinical 
diagnosis.  Clinicians who have a stronger understanding of diagnostic utility measures 
and know how to interpret them may improve their clinical reasoning skills in evaluating 
pathologies.  Specifically, diagnostic tests and screening with dichotomous outcomes 
need to be interpreted and applied beyond elemental reasoning grounded in binary 
outcomes; (e.g., a positive test automatically equates to the presence of a given 
pathology).  In the process of a clinical assessment sequence, a clinician should consider 
procedures that have high diagnostic utility and eliminate ones of little value (Denegar & 
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Cordova, 2012).  Once a clinician knows the diagnostic metrics of a special test or screen, 
the results need to be contextualized based on pre-test and post-test probabilities.  
Clinicians who have an improved ability to interpret clinical findings may arrive at more 
conclusive clinical diagnoses.  Such an approach is a departure from clinical reasoning 
anchored in experience that is based in heuristics (Kassirer, Wong, & Kopelman, 2010).  
In day-to-day clinical practice, heuristics are a problem solving short cut predicated upon 
one’s experience in recognizing general diagnostic patterns with respect to a given 
pathology.  To some extent pattern recognition relies on the likelihood of an event based 
on the typical clinical presentation of a hypothesized pathology.  This may serve a 
clinician well when a patient presents with classic signs and symptoms or in emergency 
situations when time is limited, but is prone to error in complex or atypical cases 
(Kassirer et al., 2010).  Because of the risks of misdiagnosis, it is important for clinicians 
to use clinical reasoning skills consistent with the application and interpretation of 
appropriate diagnostic tests and screenings.  This study provides a link between 
definitional concepts and interpretations of diagnostic utility measures that may facilitate 
clinical reasoning skills consistent with the evidence-based paradigm. 
Our CPM is a preliminary model based on a retrospective analysis of a single-
center cohort.  As a derivation stage model, the CPM should undergo additional 
validation and impact analysis as part of the development process before being 
generalized beyond the original sample (Portney & Watkins, 2009).  However, the model 
was consistent with the literature on two foundational points: (a) pitchers are at higher 
risk of UE SRI than field position players (Dick et al., 2007; Fleisig et al., 2010; 
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McFarland & Wasik, 1998); and (b) KJOC-SES were able to predict injury status 
(Alberta et al., 2010; Domb et al., 2010; Neri et al., 2010; Neuman et al., 2011).  The 
standard for determining positive functional outcomes in baseball athletes has historically 
been return-to-play; however, the standard of return-to-play does not adequately quantify 
an athlete’s functional status (Alberta et al., 2010).  Pragmatically, our results support the 
notion that clinicians should incorporate self-reported outcome measures as a compulsory 
element of clinical practice.  This form of clinical outcome assessment is foundational to 
EBP and should be a standard component of patient care (Sauers & Snyder, 2011).  A 
clinician could easily incorporate our CPM as part of the pre-participation physical 
process or the injury evaluation and rehabilitation examination sequence when working 
with baseball athletes.  The self-report outcomes assessments should be a routine part of 
clinical practice. Most clinicians (90%) recognize the importance of self-reported 
outcome measure; however only 48% of physical therapists incorporate them as part of 
patient assessment (Jette, Halbert, Iverson, Miceli, & Shah, 2009). The use of self-
reported outcome measures among athletic trainers is unknown (Michener, 2011). 
Beyond the aforementioned direct application, our study builds on the theoretical 
framework for developing CPMs in athletic populations to predict SRI (Bruce & 
Wilkerson, 2010a).  Developing injury prediction models similar to ours and others 
(Bruce & Wilkerson, 2010b; Wilkerson, 2010) may be advantageous in other populations 
to gain knowledge related to risk factors and SRI.  Simplistically, an athletic trainer could 
develop a CPM as part of a retrospective injury analysis as seasons end to determine risk 
factor patterns.  On a more complex level, researchers could partner with clinicians to 
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work collaboratively in developing CPMs to enhance clinical practice.  If coupled with 
measures of diagnostic utility, practitioners could find themselves at the nexus of patient-
centered evidence-based clinical practice. 
Collectively, the principles of evidence-based practice have emerged as an 
important focus within sports medicine clinical practice.  Clinicians should possess a skill 
set in understanding and applying diagnostic utility measures.  Employing CPMs to 
understand the relationship between multiple risk factors and injury are vital for 
improving diagnosis as well as treatment based prognosis.  The addition of self-reported 
outcome measures is also an important element of clinical practice that is beneficial in 
quantifying the heath and injury status of athletic populations.  Thus the scope of this 
study advances the body of knowledge in these areas of evidence-based clinical practice 
which is central to 21
st
 century health care (Evans & Lam, 2011). 
Limitations 
There are a number of limitations associated with this study that warrant 
consideration, particularly retrospective methodology, FMS reliability, and sample size.  
Researchers may not be able to control the completeness or reliability of the data 
collection process in retrospective studies (Portney & Watkins, 2009).  Individual game-
by-game statistics were only available for 11 of the 19 (58%) pitchers and eight of 17 
(47%) fielders.  This reduced the sample size for univariate analysis for the majority of 
sport performance risk factors (see Table 13).  Secondly, CKCUEST data were missing 
for two subjects, both pitchers, one with a history of UE SRI.  The reason for the missing 
data is unknown, but could have resulted from subject refusal to participate in the 
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individual FPM, a data recording error, or database entry error.  Subsequently this 
reduced the sample size from 36 to 34 for univariate analysis related to CKCUEST 
(absolute score) and CKCUEST (TEAM-S).  The multivariate analysis treated the data 
set associated with these two subjects as missing cases and excluded them the logistic 
regression statistical modeling.  Analysis of an incomplete data set may have influenced 
our findings. 
With respect to reliability, the TEAM-S was used to generate predictor variables 
related to FPM.  As a new battery of functional performance screening measures, TEAM-
S does not have established reliability or validity metrics. Although the reliability of 
TEAM-S is unknown, the individual tests that comprise the battery are similar to tests 
comprising the FMS® and the FROHM 9-Test Screen.  FMS® and the FROHM 9-Test 
Screen have been shown to be reliable (Frohm et al., 2011; Minick et al., 2010; 
Schneiders et al., 2011; Teyhen et al., 2012).  Additionally, it is important to recognize 
that the individual tests comprising the TEAM-S have established reliability metrics (see 
Table 6).  Ideally, FPM data should have been obtained from a battery of tests with an 
established composite score reliability.  However, this study was only able to obtain FPM 
through the TEAM-S process. 
The TEAM-S was administered in a field rather than a laboratory setting by 
experienced (physical therapists, certified athletic trainers, certified strength and 
condition coaches) and novice (undergraduate students) clinician/raters with minimal 
training.  The intra- and inter-rater reliability for experienced and student raters was not 
determined prior to data collection.  For the most part, individual FPMs have previously 
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demonstrated good to excellent intra- and inter-rater reliability among clinicians with 
varied experience (Minick et al., 2010; Teyhen et al., 2012). 
Sample size is critical with respect to the number of positive cases and the number 
of included predictive variables (Pallant, 2010).  It is common practice to include 10 to 
15 subjects per predictor variable in the final CPM (Glynn & Weisbach, 2011), but a 
larger sample size to account for 10 to15 subjects per potential predictor variable in the 
overall study has been suggested to avoid over-fitting a regression model  (Beneciuk, 
Bishop, & George, 2009).  In the current investigation (n = 36) there were twelve positive 
cases with five predictor variables entered into the logistic regression, which resulted in a 
two-factor CPM.  Our final model is within the constraints of 10 to 15 subjects per factor 
in the final model, but inconsistent with the suggested 10 to 15 subjects per predictor 
variable within the overall study.  A larger sample size would likely be beneficial in 
strengthening the development of a CPM on the basis of greater statistical power.  
Specifically, the model demonstrates strong diagnostic utility measures; however, the 
95% confidence intervals associated with LR+ (2.88 to 138.5), LR- (0.04 to 0.61), and 
DOR (9.32 to 1418.8) are wide.  A larger sample size would narrow the 95% confidence 
intervals and the accuracy of the diagnostic utility measures (Bruce & Wilkerson, 2010b).  
In addition to these primary concerns, other limitations should be considered.  
Injury status as the dependent outcome variable was established from self-reported 
history as part of the KJOC-SES instrument.  The KJOC-SES does not establish a time-
course for injury occurrence nor does the instrument provide an operational definition for 
what constitutes an UE SRI.  Additionally, the instrument requires ten response items 
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without temporal context.  The items require a respondent to quantify a perception 
without providing a time frame (e.g., with the past month or with the past year).  The lack 
of temporal context requires a respondent unconsciously to use subjective impressions of 
stability and change to derive an interpretive response that may be unrelated to the intent 
of the instrument’s context (Streiner & Norman, 2008).  This may bias item responses, 
causing measurement error or undermining the measurement scale’s reliability (DeVellis, 
2003).  Consequently, the recall accuracy of self-report health measures is an issue in 
health measurement scale methodology (Streiner & Norman, 2008).  This may be 
particularly true in disorders with fluctuating symptoms (e.g., osteoarthritis, depression) 
or when pain is a primary variable (Litcher-Kelly, Martino, Broderick, & Stone, 2007; 
Stone, Broderick, Kaell, DelesPaul, & Porter, 2000; Stone, Broderick, Shiffman, & 
Schwartz, 2004). However, recall accuracy of self-reported sport injury history in athletes 
has been reported to be 80% (Gabbe, Finch, Bennell, & Wajswelner, 2003). 
An additional concern related to SRI history is the number and type of injuries 
that were reported in our cohort.  Twelve (33%) of the participants had a self-reported 
history of a serious UE SRI: five ulnar collateral ligament sprains, three shoulder 
impingements, two labium pathologies, and two rotator cuff tendinopathies.  The nature 
of these self-reported injuries was consistent and representative of time-loss UE SRI 
reported in literature (Burkhart, 2006; Burkhart, Craig, & Kibler, 2003; Burkhart & 
Morgan, 2001; Cain et al., 2003; Domb et al., 2010; Gerstman et al., 2009; Jazrawi et al., 
2006; Jobe & Bradley, 1988; Kuhn, 2009; Namdari et al., 2011; Wood et al., 2010).  The 
current retrospective reporting of a 33% injury rate was similar to the 25% injury rate 
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previously reported in collegiate baseball (Dines et al., 2007).  Typically, sport injury 
rates are expressed as a ratio of injures per 1,000 units of practice and/or game exposures.  
Because of the nature of this retrospective study, we were unable to calculate an injury 
rate per 1,000 exposures to determine whether our injury rate was consistent with 
reported values of 0.54 to 5.73 per 1,000 (Dick et al., 2007; Posner et al., 2011).  It is 
important to consider that injury prevalence in the context of a small sample size may not 
reflect well the prevalence in a larger population (Portney & Watkins, 2009).  Thus 
caution is warranted in placing the results of this investigation into a broader context.  
Despite the existence of these limitations, the study fits within in the context of derivation 
stage CPM.  Our primary findings are consistent with current evidence related to UE SRI 
in baseball players.  The strength of our two-factor CPM warrants consideration in an 
appropriate context and provides a foundation for future research. 
Recommendations for Future Research 
The current findings resulted in a preliminary two-factor CPM comprised of 
KJOC-SES (≤ 86) and playing position (pitcher).  The model was developed in a small 
sample (n = 36) pooled from a single center.  It appears that the CPM is a viable clinical 
screening tool for UE SRI in baseball players.  However, the model is only consistent 
with a level IV evidence rating for CPM and should undergo additional development to 
address issues related to sample size, validity, and impact analysis (Portney & Watkins, 
2009). 
The natural progression for CPM development after the derivation stage is 
validation and impact analysis (Childs & Cleland, 2006; Toll, Janssen, Vergouwe, & 
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Moons, 2008).  Validation encompasses reproduction of the CPM to assess the model’s 
metrics in a different or expanded population set.  Validation also may entail 
conformation of the original set of predictor variables or consideration of alternative 
variables that were excluded from the initial design.  On a basic level, our CPM and its 
diagnostic utility metrics need to be conformed in a larger sample.  This should occur in a 
prospective design to determine whether the retrospective diagnostic properties of the 
model are transferable to a prognostic screening tool. 
The greater challenge of validating the model would be to update the preliminary 
set of contributory variables (Toll et al., 2008).  Our predictor variables were derived 
from the KJOC-SES, sport performance statistics, and the TEAM-S.  Due to the 
availability of retrospective data, we obviously could not address the full spectrum of risk 
factors previously identified as causal for UE SRI in baseball athletes.  Specifically, we 
did not include direct measurements of muscle strength deficits (Brown et al., 1988; 
Yildiz et al., 2006), muscle fatigue (Mullaney et al., 2005), internal and external strength 
imbalance (Lewis & Valentine, 2007), GIRD (Borsa et al., 2006; Dines et al., 2009; Wilk 
et al., 2010), maximum pitching velocity (Bushnell et al., 2010), or throwing 
biomechanics (Fleisig et al., 1995; Fleisig et al., 1996).  Conceptually we categorized risk 
factors into three areas consisting of (a) self-reported outcome scores; (b) sport 
performance factors; and (c) FPM.  Future studies should include direct measures such as 
muscle strength deficits, muscle fatigue, internal and external strength imbalance, GIRD, 
maximum pitch velocity, or biomechanics.  This may improve understanding of the 
multifactorial relationship between risk factors and UE SRI.  It may generate a different 
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model that includes a set of modifiable predictor variables (e.g., strength imbalance, 
ROM deficits) that could translate into a specific injury prevention program. 
In addition to the recommendation for expanding the number of risk factors, it is 
important to consider the role of FPM in clinical research.  Our results provide additional 
confirmation on the lack of evidence between FPM batteries and injury prediction.  
Future work in this area should focus on clarifying the TEAM-S normative values and 
envelope of function.  This may contribute to establishing the reliability and validity of 
TEAM-S in identifying functional limitations and injury risk in athlete populations. 
Impact analysis of CPM pertains to how a model is utilized by clinicians, affects 
clinical decision making, and improves patient outcomes (Toll et al., 2008).  The 
fundamental issue relating to impact analysis centers on sensibility and begs the question: 
“Can a CPM be easily incorporated into route clinical practice, produce interpretable 
results, and lead to tangible patient-oriented outcomes?” (C. E. Cook, 2008).  One might 
assume that our two-factor CPM could be incorporated easily into clinical practice as a 
pre-season baseline measure.  However, the use of self-report outcome measures has been 
lacking in sports medicine settings such as athletic training.  Translational research may 
help orient clinicians to how a CPM can be implemented and applied in sports injury 
management and rehabilitation.  This in turn may lead to evidence that demonstrates how 
a CPM shapes clinical decision making and leads to improved patient-oriented outcomes. 
The logical next step in our research centers on two potential approaches, the first 
of which is to employ the KJOC-SES as a prognostic screening tool.  Through 
retrospective design, the KJOC-SES has demonstrated respectable diagnostic utility in 
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identifying overhead athletes with UE SRI and self-reported functional limitations.  The 
question that remains is whether the KJOC-SES can predict injury prospectively.  
Investigating this question would benefit identifying individual athletes for preventive 
treatment strategies. Second, the work of Wilkerson (2010) provides evidence that self-
reported outcome measures coupled with select FPMs that assess altered neuromuscular 
activation patterns (e.g., muscular endurance fatigue) are supported as a preseason injury-
risk screening tool in collegiate football players.  A similar approach in baseball athletes 
has not yet been established.  Moving forward, research that combines the KJOC-SES 
with modifiable neuromuscular risk factors may provide a more definitive CPM in 
predicting UE SRI in baseball players.  
Conclusion 
Based on the findings of this study, a preliminary two-factor CPM comprised of 
KJOC-SES (≤ 86) and playing position (pitcher) retrospectively predicted UE SRI in a 
cohort of baseball players with strong diagnostic utility.  The CPM demonstrated greater 
diagnostic utility than did individual risk factors in predicting UE SRI in injured versus 
non-injured groups.  Although retrospective designs and derivation models have 
limitations, the two-factor CPM improves on current understanding of risk factors and 
UE SRI in baseball.  The diagnostic utility measures for the two-factor CPM in this 
population have not been reported previously and comprise a novel approach to injury 
evaluation consistent with the evidence-based paradigm. 
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APPENDIX A 
KERLAN-JOBE ORTHOPAEDIC CLINIC SHOULDER & ELBOW SCORE  
(KJOC-SES) 
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APPENDIX B 
TARGETED ENHANCED ATHLETIC MOVEMENT SCREEN (TEAM-S) 
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Athlete’s Name: 
 
Date today: 
 
Date of Birth: 
 
Age:     Gender (circle one):    Male Female 
 
Sport: 
 
Position: 
 
Year in School: 
 
 
 
 
 
 
 
TOTAL SCORE: _________/75  
 
X 100= ____________% 
 
Scoring is done by taking the score of each individual test and adding them together. 
If the test has more than 1 score (ex: left and right scores) then the LOWEST of 
those scores is taken to compute the overall TOTAL SCORE.   
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SCORING SHEETS 
 
1. BEIGHTON HYPERMOBILITY 
 
 
 L  R 
Hands on the floor with knees straight  1  
Elbow hyperextension 1  1 
Knee hyperextension 1  1 
Thumb to forearm 1  1 
Little finger 90 degrees or more 1  1 
TOTAL ________/9 
points 0-1 2-3 4-5 6-7 8-9 pain 
SCORE 5 4 3 2 1 0 
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2. FULL SQUAT 
  
Description: 
3 reps to allow views from different 
angles 
PVC overhead and 2x4 under heels as 
needed. Feet shoulder width apart, toes 
point straight ahead, heels stay on 
ground, squat below parallel 
 
Common Errors: Knees to midline, heels come off ground, shoulders flex forward, 
lean left or right, toes rotate out 
Score (check one): COMMENTS: 
Full squat (below 
90), no substitutions 
 
5 
 
Squat to parallel, no 
substitutions  
4  
Full squat with 2x4 
no substitutions 
3  
Squat to parallel with 
2x4, no substitutions 
 
2 
 
Unable to squat 
without substitutions 
to parallel even with 
a 2x4 
 
1 
 
Pain with test 0  
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3. SINGLE LEG SQUAT 
  
Description: 
5 reps with worst of last 2 reps scored.  
Subject stands on 1 leg and touches their 
rear to a stool, then stands back up. The 
stool is at a height where the squat is 
parallel to the floor (90 deg). Watch for 
the common errors listed below 
 
Common Errors: Loss of balance, knees to midline, lack of depth, toe in/out, lateral 
trunk lean 
Score (check one): COMMENTS: 
  
L 
 
R 
 
0-1 error present 5 
 
5 
 
 
2 errors present 4 
 
4 
 
 
3 errors present 3 
 
3 
 
 
4 errors present 2 
 
2 
 
 
5+ errors present  
1 
 
1 
 
Pain with test 0 0  
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4. Downward Dog 
  
Description: 
Start on all fours, knees under hips and 
hands one hand length in front of 
shoulders. Straighten legs and arms, 
flattening scapula to back forming and 
inverted V.  
Common Errors: heels don’t touch ground, inverted U shape 
Score (check one): COMMENTS: 
patient able to touch 
heels to floor and 
assume inverted V 
position 
5 
 
 
both heels to floor 
with adjusted hand 
position, and flat 
back 
4 
 
 
both heels to floor 
with adjusted hand 
position and rounded 
back 
3 
 
 
one heel to floor with 
other leg lifted 
straight back 
2 
 
 
unable to get heel to 
floor with one leg 
lifted straight back 
 
1 
 
Pain with test 0  
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5. Active Straight Leg Raise 
  
Description: 
Patient lays on back with legs straight, 
toes pointing toward ceiling and 2x4 
under knees. Arms flat on ground. 
Instruct subject to lift their leg keeping it 
straight. Examiner places dowel in line 
with the medial malleolus. Test is named 
for the leg lifted 
 
Common Errors: bent knee on either leg, leg rotates outward (either leg) 
Score (check one): COMMENTS: 
  
L 
 
R 
 
dowel lines up with 
greater trochanter 
(GT) or above 
(90+degrees of hip 
flexion) 
5 
 
5 
 
 
dowel lines up 
between mid-thigh 
and GT 
4 
 
4 
 
 
dowel lines up 
between patella and 
mid-thigh 
3 
 
3 
 
 
dowel lines up 
between patella and 
mid-shin 
2 
 
2 
 
 
dowel lines up below 
mid-shin 
 
1 
 
1 
 
Pain with test 
 
0 0  
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6. Shoulder Mobility Test 
 
 
Description: 
First, measure the patient’s hand length 
from the wrist crease to the tip of the 
middle finger and record below. The 
test is named for the arm that is behind 
the back. Make a fist and reach behind 
the head as far as possible. Make a fist 
with the opposite hand and reach behind 
the back as far up as possible 
 
Common Errors: trying to “crawl” the hands closer together, scapular winging, 
poor motion 
 
HAND LENGTH:           L __________     R__________ 
Score (check one): COMMENTS: 
  
L 
 
R 
 
fists touch without 
scapular winging 
5 
 
5 
 
 
fists within one hand 
length no winging 
4 
 
4 
 
 
fists within one hand 
length or closer with 
winging 
3 
 
3 
 
 
fists between 1 and 2 
hand lengths-  with 
or without winging  
2 
 
2 
 
 
fists greater than 2 
hand with or without 
winging lengths 
apart-  
 
1 
 
1 
 
Pain with test 
 
0 0  
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7. Y-Balance for UE 
                           
Trial 
Reach 
Directio
n 
1 
 
L         
R 
2 
 
L         
R 
3 
 
L         
R 
Lateral 
 
      
Overhe
ad 
      
Undern
eath 
      
 
Description: 
Measure C7 spinous process to longest 
fingertip with arm in 90 degrees 
abduction. Assume push-up position. 3 
trials will be performed in each direction. 
All 3 directions (lateral, inferomedial, 
superomedial) performed without rest. 
The sum of the greatest reach in each 
direction is divided by 3x the limb length 
then multiplied by 100. Test is named for 
the non-reaching arm 
 
 
Common Errors: trying to “crawl” the hands closer together, scapular winging, 
poor motion 
LIMB LENGTH:           L __________     R__________ 
 
Sum of greatest 3 reaches:     L_________/3  x 100= _______________ 
 
                                                            R_________/3 x 100= _______________ 
Score (check one): COMMENTS: 
one arm 95%-100% 
of the other 
5 
 
 
One arm 90%- 94% 
of the other 
4 
 
 
One arm 85%- 89% 
of the other 
3 
 
 
One arm 80%- 84% 
of the other 
2 
 
 
One arm 79% or less 
of the other 
 
1 
 
Pain with test 
 
0  
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8. CKCUEST 
 
Description: 
2 pieces of tape 36 inches apart. Athlete 
places their arms in a shoulder width, 
push-up position between the pieces of 
tape. Athlete alternates touching the 
pieces of tape. Record # of cross-body 
touches in 15 sec 
 
Common Errors: poor quickness 
Score (check one): COMMENTS: 
patient able to touch 
30+ times 
5 
 
 
patient able to touch 
25-29 times 
4 
 
 
patient able to touch 
20-24 times 
3 
 
 
patient able to touch 
15-19 times 
2 
 
 
patient able to touch 
14 or less times  
 
1 
 
Pain with test 0  
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9. Side Plank Hip Abduction 
  
Description: 
Subject is in a side plank position on 
elbow with feet together and opposite 
hand on hips. Only bottom foot (not leg) 
and elbow should touch the ground. Lift 
top leg at least 8 inches and return to 
start as many times as possible in 30 sec. 
Rest 2 minutes, and repeat on the 
opposite side. Test is named for the leg 
lifted 
 
Common Errors: top leg cannot be lifted, top leg flexes forward during test, entire 
lower leg of bottom leg touches the ground, trunk flexes  
Score (check one): COMMENTS: 
  
L 
 
R 
 
30+ reps 5 
 
5 
 
 
25-29 4 
 
4 
 
 
20-24 3 
 
3 
 
 
15-19 2 
 
2 
 
 
14 or less  
1 
 
1 
 
Pain with test 
 
0 0  
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10. Side Plank Hip Adduction 
  Description: 
Subject is in a side plank position on 
elbow with one foot touching the ground 
and the other resting on a bench. Or 
chair The opposite hand rests on hips. 
Only bottom foot (not leg) and elbow 
should touch the ground. Lift bottom leg 
at least 8 inches and return to start as 
many times as possible in 30 sec. Rest 2 
minutes, and repeat on the opposite side. 
Test is named for the leg lifted 
 
Common Errors: bottom leg cannot be lifted, bottom leg flexes forward during test, 
entire lower leg of bottom leg touches the ground, trunk flexes  
Score (check one): COMMENTS: 
  
L 
 
R 
 
35+ reps 5 
 
5 
 
 
30-34 4 
 
4 
 
 
25-29 3 
 
3 
 
 
20-24 2 
 
2 
 
 
23 or less  
1 
 
1 
 
Pain with test 
 
0 0  
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11. Nordic Hamstring Test 
 
Description: 
Subject kneels and 
examiner holds ankles. 
Keeping a perfectly 
straight body with arms 
at the ready (push-up 
position), the subject 
leans slowly forward. 
Examiner measures knee 
flexion angle at failure 
(athlete lets go) 
 
Common Errors: butt sticks out, trunk flexes, hamstring cramp 
Score (check one): COMMENTS: 
45 degrees + 5 
 
 
35-44 degrees 4 
 
 
25-34 degrees 3 
 
 
15-24 degrees 2 
 
 
5-14 degrees   
1 
 
Pain with test or less than 5 
degrees 
0  
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12. Triple Hop for Distance 
  
Description: 
Measure leg length in standing from ASIS 
to beneath the lateral malleolus. Hands on 
hips, jump and land 3 consecutive times 
on the same leg. Each athlete may have 
one practice trial. They must stick the 
landing. Record the total distance jumped 
on each leg. The hop will he measured 
from the starting line to the back of the 
heel after the third hop on each trial. 
Common Errors: use of hands, fall off balance 
 
LIMB LENGTH:           L __________     R__________ 
 
Distance hopped:     L_________  R_________  
 
Least distance/greatest distance x 100= _______________ 
 
Score (check one): COMMENTS: 
one leg 95%-100% of 
the other 
5 
 
 
One leg 90%- 94% of 
the other 
4 
 
 
One leg 85%- 89% of 
the other 
3 
 
 
One leg 80%- 84% of 
the other 
2 
 
 
One leg 79% or less 
of the other 
 
1 
 
Pain with test 
 
0  
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13. Vertical Leap 
 
Description: 
First, record stand-and-reach height by 
having the participant extend the 
preferred reach hand as high as possible 
with feet flat on the floor. Subject 
should bend the hips and knees, and, 
without pausing, jump as high as 
possible. Arm swing is allowed. Record 
jump-and-reach height. VJ height is 
calculated by subtracting the stand-and-
reach height from the jump-and-reach 
height. Participants are permitted 1 
practice jump before completing 3 test 
trials. The maximal height reached 
during the 3 test trials is recorded. 
 
Common Errors: any steps taken 
 
(a)Stand and reach height: ____________in.   (b)Jump and Reach Height: 
_________in. 
 
VJ Height: (b) – (a) ________________in. 
Score (check one): COMMENTS: 
Men- 30+ in. 
Women- 20+ in. 
5 
 
 
Men- 26-29 in. 
Women- 16-19 in. 
4 
 
 
Men- 22-25 in. 
Women- 12-15 in. 
3 
 
 
Men- 18-21 in. 
Women- 8-11 in. 
2 
 
 
Men- 17 or less in.  
Women- 7 or less in. 
 
1 
 
Pain with test  0  
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14. In-Line Lunge for Distance 
 Description: 
First, measure leg length from beneath 
the ASIS to beneath the lateral 
malleolus. Toes are behind a line on the 
floor, hands on hips. Subject steps out as 
far as possible with one leg while toe of 
the other leg must stay behind the start 
line. Measure distance by heel of the 
lead leg.  Take the best of 3 trials for 
each leg. The test is named for the 
trail leg 
 
Common Errors: dragging the rear foot forward, losing balance  
 
LIMB LENGTH:           L __________ in.     R__________ in. 
 
Distance Lunged:     L_________ in.  R_________ in. 
 
Score (check one): COMMENTS: 
  
L 
 
R 
 
one leg 95%-100% 
of the other 
5 
 
5 
 
 
One leg 90%- 94% 
of the other 
4 
 
4 
 
 
One leg 85%- 89% 
of the other 
3 
 
3 
 
 
One leg 80%- 84% 
of the other 
2 
 
2 
 
 
One leg 79% or less 
of the other 
 
1 
 
1 
 
Pain with test 
 
0 0  
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15. Lateral Lunge for Distance 
 
Description: 
First, measure leg length from beneath 
the ASIS to beneath the lateral 
malleolus. Medial aspect of trail leg is 
behind a line on the floor, hands on hips. 
Subject steps out as far as possible with 
one leg while foot of the other leg must 
stay behind the start line and flat to the 
floor. Measure distance by the medial 
border of the lead leg (toes pointing 
straight ahead). Take the best of 3 trials 
for each leg. 
The test is named for the trail leg 
 
Common Errors: dragging the rear foot forward, losing balance, rotating the lead 
foot outward  
 
LIMB LENGTH:           L __________ in.     R__________ in. 
 
Distance Lunged:     L_________ in.  R_________ in. 
 
Score (check one): COMMENTS: 
  
L 
 
R 
 
one leg 95%-100% 
of the other 
5 
 
5 
 
 
One leg 90%- 94% 
of the other 
4 
 
4 
 
 
One leg 85%- 89% 
of the other 
3 
 
3 
 
 
One leg 80%- 84% 
of the other 
2 
 
2 
 
 
One leg 79% or less 
of the other 
 
1 
 
1 
 
Pain with test 
 
0 0  
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APPENDIX C 
 
HIGH POINT UNIVERSITY INSTITUTIONAL REVIEW BOARD PROTOCOL 
APPROVAL 
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APPENDIX D 
 
INFORMED CONSENT FORM  
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APPENDIX E 
RECEIVER OPERATOR CHARACTERISTIC (ROC) CURVES 
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Figure E1.  ROC Curve for KJOC-SES Score  
AUC = 0.854.  
 
 
 
Figure E2. ROC Curve for CKCUEST Absolute Score 
AUC = 0.698. 
 
 
 
